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Pancreatic beta cells cultured in 2D systems display similar characteristics to 
dysfunctional beta cells of patients with diabetes. This thesis explores the impact of cell 




The MIN6 mouse beta cell line was cultured as 2D monolayers and 3D structures named 
pseudoislets. The insulin secretion response and metabolic function of 2D and 3D MIN6 
cultures, along with islets from human donors were compared. Roles for cell-cell 
interactions in regulating metabolic changes were explored with focus on the gap 




MIN6 pseudoislets displayed improved functional responses compared to monolayers 
with 7.4-fold and 1.5-fold increases in glucose-induced insulin secretion respectively. 
XFe24 seahorse bioanalyser data showed the improved glucose-stimulated 
pseudoislet response was fuelled by large increases in glycolytic flux and a more 
moderate increase in oxidative phosphorylation. Basal insulin secretion and basal 
oxidative phosphorylation were both higher in monolayers but there were no 
differences in basal glycolysis. Human islets displayed a similar phenotype to 
pseudoislets with high contributions of glycolysis to glucose-induced ATP production. 
Pseudoislets indicated some hypoxia through trends towards increased lactate 
dehydrogenase and phosphoinositide-dependent kinase-1 expression and increased 
glycolytic activity of phosphfructokinase-1 and glyceraldehyde 3-phosphate 
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dehydrogenase but superior glucose sensing through decreased hexokinase I and 
increased GLUT2 expression and more active mitochondrial activities of pyruvate 
carboxylase, citrate synthase, α-ketoglutarate dehydrogenase, and malate 
dehydrogenase. Knockdown of connexin36 did not alter glucose-stimulated insulin 
secretion or metabolic flux. However, there was a trend towards increased basal 
insulin secretion and basal oxidative phosphorylation indicating a possible role for 




The improved glucose-stimulated secretion conferred by pseudoislet configuration was 
accompanied by an increase in ATP production suggesting a role for alteration in 
metabolic flux in the improved functionality. Improved functional responses of beta cells 
in 3D structures was accompanied by a small increase in oxidative phosphorylation but 
a large increase in glycolysis that cannot be fully explained by hypoxia. Connexin36 may 
play a role in regulating the basal response but other connections are involved in 
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CHAPTER 1. INTRODUCTION 
 
1.1. Regulation of Blood Glucose 
 
Blood glucose levels are maintained within strict boundaries between 4mmol/l and 
7.8mmol/l to maintain blood glucose homeostasis and avoid detrimental effects of 
hyperglycaemia. Islets of Langerhans are essential for blood glucose homeostasis, these 
are regions of endocrine tissue contained within the pancreas. Cells within these islets 
monitor glucose levels and respond to low and high glucose by synthesising and 
releasing glucagon and insulin [1]. Following a rise in blood glucose, such as after a meal, 
insulin released by beta cells binds to receptors on cells of insulin sensitive tissues to 
initiate three key responses that counteract the rise of glucose. Uptake of glucose into 
muscle, fat and liver cells is increased; storage of glucose as glycogen in the liver through 
glycogenesis is upregulated; and the production of glucose through gluconeogenesis is 
inhibited. When blood glucose levels begin to drop due to exercise or lack of food, 
glucagon triggers the conversion of glycogen back to glucose and the production of 
glucose through gluconeogenesis restoring the homeostatic balance. The ability of beta 
cells to regulate blood glucose via insulin can be compromised; the conditions where 
this occurs are collectively termed diabetes mellitus [2]. 
 
1.2. Islet Architecture 
 
Islets of Langerhans consist of three main cell types, insulin producing beta cells, 
glucagon producing alpha cells, and somatostatin producing delta cells. Due to the high 
availability, relatively low costs, and ease of genetic selection, rodent islets are often 
used experimentally to further understanding of islet biology and further develop 
therapeutic options for patients with diabetes [3]. Figure 1 shows the structures of 
rodent and primate islets. Both consist mostly of beta cells along with alpha cells, delta 
cells and blood vessels that provide the islet with oxygen and metabolic cues [4]. The 
beta cells of rodent islets are located mostly in the core and surrounded by alpha and 
delta cells, while primate islets have a more heterogeneous distribution of cell types. A 
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small proportion of the islet, <5%, is made up of cells not pictured in figure 1. These 
include pancreatic polypeptide producing PP cells and ghrelin producing epsilon cells 
and are randomly distributed throughout primate islets and found mostly around the 
beta cell core of rodent islets  [5]. The primate islet contains a lower proportion of beta 
cells than the rodent islet, 65% compared to 80% respectively. Despite some differences 
in the islet architecture, both rodent and primate islets display a robust insulin secretion 
response stimulated through similar metabolic pathways meaning rodent islets are 
often used in islet studies [6-16]. 
 
Figure 1. Diagram showing the architecture of rodent and primate islets [4]. 
 
1.3. Diabetes Mellitus 
 
1.3.1. Type 1 Diabetes  
 
Type 1 diabetes mellitus (T1DM) accounts for 5-10% of people diagnosed with diabetes. 
It is a chronic disease characterised by autoimmune destruction of insulin-producing 
beta cells, leading to absolute insulin deficiency [17]. The cause is the combination of a 
genetic predisposition and one or more environmental triggers, which are currently 
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poorly defined but are thought to include viral infections, stress and diet [18]. 
Presentation of the disease typically occurs between the ages of 5 and 7 years although 
it can present later in life and the onset can be variable, often slower in adults [19]. 
Symptoms develop over several weeks or days and typically begin at 90-95% β-cell loss. 
They can range from severe hyperglycaemia and ketoacidosis, to excessive thirst, 
urination, tiredness and weight loss [17]. 
 
1.3.2. Type 2 Diabetes 
 
As opposed to T1DM, patients with Type 2 diabetes mellitus (T2DM) do not suffer from 
absolute insulin deficiency, but experience a relative insulin decrease as well as 
peripheral insulin resistance [20]. There are five stages in the progression of beta cell 
dysfunction towards T2DM described by Weir in 2004 [21]. First is compensation where 
the rate of insulin secretion increases to compensate for increasing insulin resistance. 
The second is stable adaption characterised by fasting blood glucose levels between 5.0 
and 7.3mmol/l, blood glucose levels in this stage can be maintained at these levels for 
years with the right diet and exercise regimen. Beta cells in stage two display impeded 
GSIS. Stage three is known as unstable early decompensation, this is a relatively short 
phase in which beta cells reach a critical stage due to loss of beta cell mass and/or 
increases in insulin resistance leading in a rapid increase in blood glucose levels until 
they stabilise in stage four at ~16–20mmol/l. Patients in stage four, stable 
decompensation, retain enough insulin secretion to avoid diabetic ketoacidosis and will 
often remain in this stage for the remainder of their lives. Patients reaching stage five, 
severe decompensation, are reliant on exogenous insulin to maintain blood glucose 
levels but it is rare for T2DM patients to progress to this stage [21]. The primary cause 
of T2DM is obesity; other risk factors include genetics, lack of physical activity, and 
increasing age. The incidence of T2DM correlates with the increase in life expectancy, 
world population, and levels of obesity. It is estimated that the prevalence of diabetes 
mellitus will increase from 2.8% of the world population in 2000, to 4.4% by 2030 [22]. 
T2DM can take years to diagnose as the symptoms are less obvious. However, if 
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untreated the high glucose levels can cause damage to the microvascular and 
macrovascular systems [23]. 
 
1.3.3. Complications Associated with Diabetes 
 
Hypoglycaemic attacks more typically associated with T1DM, range in severity. Mild 
hypoglycaemia can be recognised by symptoms such as blurred vision, confusion, and 
shaking. During a severe hypoglycaemic attack, the availability of glucose to the brain is 
reduced and can result in a diabetic coma, which if untreated can lead to death. 
Hyperglycaemia leads to microvascular complications such as nephropathy, retinopathy, 
and neuropathy and macrovascular complications such as cardiovascular disease [24, 
25]. Complications caused by hyperglycaemia affect most patients with diabetes and can 
seriously impact on the patients’ quality of life and life expectancy. Around 60% of T2DM 
patients' deaths are caused by cardiovascular disease [26] and more than 10% of annual 
healthcare spending in developed countries is currently spent on diabetes and its related 
conditions [27]. Tight control of blood glucose levels can help reduce the impact of these 
complications making the development of effective treatments essential.  
1.4. Current Treatments for T1DM 
 
1.4.1. Exogenous Insulin 
 
The current standard treatment for T1DM is injection with exogenous insulin, 
administered through multiple daily injections or continuous subcutaneous insulin 
infusions. These infusions consist of a combination of rapid or short acting insulin around 
mealtimes and long or medium acting insulins to provide background insulin throughout 
the day. Continual insulin therapy with regular blood glucose testing has the capability 
to dramatically increase quality of life [25]. Unfortunately the treatment for T1DM is an 
expensive one meaning that there are many patients, primarily in developing countries 
who are not able to access the necessary treatments and hence have a very poor 
prognosis [28].  For those able to access it, exogenous insulin is not a perfect treatment 
as it is not able to mimic the actions of endogenous insulin completely. The dosage 
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required varies depending on food eaten and physical activity. This means it can be 
difficult to calculate, especially in the early stages of diagnosis, leading to large 
fluctuations in blood glucose [25]. 
1.3.2. Islet Transplantation 
 
Islet transplantation is a current treatment option for patients with T1DM, who are 
unable to regulate their blood glucose levels through exogenous insulin therapies and 
have reduced hypoglycaemia awareness. These patients are at high risk of microvascular 
and macrovascular diseases. Islets are isolated from a donor pancreas and infused into 
the patient's liver through the portal vein as shown in Figure 2 [29]. 
 
Of the patients who received transplants between 2007 and 2010, 44% were insulin 
independent after 3 years (Figure 3 [30]). Partial function of the graft can provide 
protection from severe hypoglycaemia and hypoglycaemic unawareness. By 2017,  more 
than 1500 patients had received islet transplantations [31]. The Collaborative Islet 
transplant Registry (CITR) reported that by 2012 44% of patients were free of severe 
hypoglycaemic events four years post-transplant and the most recent CITR report states 
that around 20% of recipients are insulin independent at five years post-transplant [32].  
 
Figure 2. Image depicting process of islet isolation and transplantation from 




1.3.3. Islet Isolation 
 
Before transplantation, islets must first be isolated from the surrounding exocrine tissue 
of the donor pancreas by enzymatic digestion, as was first described in 1965 [33]. Lacy 
and Kostianovsky used these enzymatic digestion techniques, along with gradient 
purification, to successfully isolate metabolically active islets from the pancreas of 
rodents [34]. The islets were transplanted into diabetic rats, resulting in some recovery 
of glucose control [34]. Isolation and purification techniques continued to improve, and 
human islet transplantation trials began in the mid 1980’s. Subsequent studies showed 
that long term insulin independence could be achieved in humans through islet 
transplants, but with a limited success rate (16-18). Between 1990 and 2001, 267 islet 
transplants were recorded in the Islet Transplant Registry but only 8.2% of these 
achieved insulin independence for over one year [35] [36].  
 
The success rates of islet transplantations improved following the publication of a study 
by the Edmonton group, who reported insulin independence in all seven recipients at 
one-year post-transplant. The key changes introduced in the Edmonton protocol include 
Figure 3. Rate of insulin independence after islet infusion as reported by the 




an increase in the number of islets transplanted and a steroid-free immunosuppressive 
regime [37]. Although the outcomes of islet transplants have improved, the treatment 
still has limitations which prevent it from being a widely available option for patients.  
 
1.3.4. Limitations of Islet Transplantation 
 
The long-term success of islet transplantation is highly variable between patients. A low 
donor availability along with other limiting factors mean that the treatment is not widely 
available. Careful selection of donors and recipients has resulted in a steady 
improvement in patient outcome over the last few years [38]. 
 
The isolation and processing techniques used to prepare the islets for transplantation 
also influence patient outcome. During isolation the beta cells within the islets begin to 
lose some function, causing them to become less responsive to stimuli such as glucose. 
Patients often require multiple infusions from different donors so understanding why 
function is lost and how to maintain it could lower the number of infusions needed 
allowing more patients to benefit from the same number of donors [39]. Improvements 
have been made in the enzymatic isolation and purification methods of islets from the 
pancreas. The use of enzyme blends containing class I collagenase and class II 
collagenase, along with varying concentrations of non-collagenolytic enzymes, allows 
digestion to be tailored to the requirements of each pancreas [12, 40]. Careful control 
over digestion is necessary as too much can cause islets to fragment and disintegrate 
reducing viability and yield.  
 
A clearer understanding of mechanisms involved in the loss of function in transplanted 
beta cells could lead to improved isolation and preparation of pancreas endocrine tissue 
before transplantation and hence improved treatment of T1DM. Optimising the culture 
conditions beta cells are exposed to between extraction and implantation is a necessary 
step towards retaining greater beta cell function.  
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1.5. Pancreatic Β-cell Physiology 
 
1.5.1. Regulation of Insulin Secretion 
 
Glucose metabolism within beta cells provides the primary stimulus for the secretion of 
insulin. Amino and fatty acid metabolism also contribute to signals resulting in release 
of insulin. Glucose is transported into the beta cell through glucose transporters; GLUT1 
in human and GLUT2 in rodent cells, [41] causing a rapid increase in intracellular glucose 
levels [30] [42]. The glucose is then phosphorylated by glucokinase in the rate limiting 
step of glycolysis. The glycolytic pathway leads to the production of pyruvate. During 
aerobic metabolism the pyruvate is oxidised to form one of two metabolites that can be 
transported into the mitochondria for further metabolism and optimum energy 
production. The metabolism of glucose through glycolytic and mitochondrial 
metabolism results in an increase in the ATP to ADP ratio which causes ATP sensitive 
potassium (KATP) channels situated in the plasma membrane to close and the membrane 
to depolarise. The KATP channels are composed of a core made of Kir6.2 and a regulatory 
subunit made of sulfonylurea receptor 1 (SUR1). Voltage gated Ca2+ channels open in 
response to the depolarised membrane allowing influx of Ca2+ ions into the cell. An 
increase in intracellular Ca2+ is essential for the activation of exocytosis of insulin 
containing granules (Figure 4). The importance of KATP channels in the insulin secretion 
pathway has been demonstrated through the addition of pharmacological agents such 
as sulfonylureas that bind to and induce closure of KATP channels depolarising the 
membrane and triggering insulin release. Agents such as diazoxide that interact with 
SUR1 to open KATP channels have been shown to inhibit glucose stimulated insulin 




Figure 4. Βeta-cell insulin secretion mechanism in response to glucose stimulus. 
Abbreviations: monocarboxylate transporter 1 (MCT-1), lactate dehydrogenase 
(LDH), glucose transporter (GLUT2), glucokinase (GK), pyruvate (Pyr), tricarboxylic 
acid cycle (TCA), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), adenosine 
triphosphate (ATP), mitochondrial calcium uniporter (MCU), nicotinic acid adenine 
dinucleotide phosphate (NAADP), exchange protein directly activated by cAMP 
(EPAC2), protein kinase A (PKA), cholecystokinin (CCK), glucagon-like peptide 1 (GLP-
1), glucose dependent insulinotropic polypeptide (GIP), vasoactive intestinal peptide 
(VIP), and peptide YY (PYY). [44] 
 
In addition to glucose-stimulated secretion, secretagogues such as gut-derived incretins 
amplify the insulin release under high glucose conditions [45]. These include glucagon-
like peptide-1 (GLP-1), glucose dependent insulinotropic polypeptide (GIP), 
cholecystokinin (CCK), peptide YY (PYY), and oxyntomodulin which are released in 
response to food transit [46]. These incretins trigger an increase in intracellular cAMP 
through the activation of G protein-coupled receptors [44]. Insulin secretion can also be 




An alternative mechanism for GSIS that is not reliant on Ca2+ oscillations was discovered 
by blocking the KATP channels using sulfonylurea [47], this is known as the KATP channel 
independent pathway. This pathway has been shown to function in the absence of 
extracellular Ca2+ and to a higher extent when the intracellular Ca2+ concentration is 
consistently high [48]. The mechanism for this pathway is still unclear but is thought to 
involve coupling factors such as NAD(P)H, glutamate, Acyl CoA, reactive oxygen species, 
and / or AMP activated protein kinase (AMPK) [44]. 
 
GSIS is biphasic. This is possibly due to two distinct pools of insulin granules, one docked 
to the plasma membrane ready for release, and one that requires trafficking to the 
membrane [49]. It is proposed that the initial pulse is caused by the release of docked 
insulin granules responding to the Ca2+ increase driven by glucose metabolism and the 
second pulse of insulin is triggered by subsequent oscillations in Ca2+ [50]. The Ca2+ 
oscillations are thought to be regulated in part by the positive product feedback of 
glycolytic enzyme phosphofructokinase (PFK).  
 
1.5.2. Metabolic Phenotype 
 
For optimal insulin secretion in response to glucose it is important that glycolytic and 
mitochondrial metabolism are tightly coupled to produce the maximum amount of ATP 
with oxidative phosphorylation being the main source of ATP. It is estimated that 
mitochondrial metabolism generates 98% of beta cell ATP production [51]. The 
conversion of glucose to pyruvate through glycolysis is shown in figure 5 [52] then, once 
the pyruvate has been shuttled into the mitochondria, it is metabolised through the 




Figure 5. Schematic showing the steps involved in glycolysis leading to the 





Tight coupling between glycolysis and mitochondrial metabolism relies on a number of 
characteristics of the beta cell such as the expression of glycerol-3-phosphate and 
malate/aspartate shuttles that transfer glycolytic derivatives into the mitochondria for 
ATP generation, and low hexokinase-1 [53], lactate dehydrogenase (LDH), and 
monocarboxylate transporter (MCT) expression [54, 55], as well as the presence of 
anaplerotic reactions [56]. To achieve these metabolic characteristics, the beta cell relies 
on a specific metabolic phenotype comprising several allowed and disallowed genes. 
expression These genes are listed in table 1.  
Figure 6. Schematics showing enzymes and intermediates involved in the TCA cycle 






Table 1. Metabolic phenotype for optimal insulin secretion 
 
The expression of either GLUT1 or GLUT2 ensures that rapid equilibrium between the 
extracellular and intracellular glucose concentrations is achieved. This enables the beta 
cell to respond quickly to small changes in blood glucose concentration.  
 
Glucokinase is the rate limiting step for GSIS due to its high S0.5 for glucose ensuring that 
it is most active at physiological glucose concentrations. Due to this it is deemed the 
glucose sensor for GSIS and ensures low rates of insulin secretion [57]. This step relies 
on exclusive expression of glucokinase with minimal expression of low Km hexokinase 
isoforms [58]. The utilisation  of glucose-6-phosphate in other pathways such as 
glycogen synthesis and the pentose-phosphate pathway is low enabling most of the 
glucose to enter the glycolytic pathway [59]. The cytosolic NADPH/NADP+ 
ratio increases in response to increased pyruvate/malate shuttle activity resulting in 
further inhibition of the pentose-phosphate pathway. 
 
A high NAD:NADH ratio is required by the beta cell to sustain glycolytic flux. However, 
the low LDH activity in the beta cell means NAD+ cannot be regenerated through the 
production of lactate as it is in other cell types. High expression of the G3P and malate 
aspartate shuttles are therefore necessary for the transfer of reducing equivalents into 
the mitochondrial matrix and the regeneration of NAD+ in the cytosol. The G3P shuttle 
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(Figure 7) converts dihydroxyacetone phosphate to glycerol-3-phosphate in the cytosol 
in a NADH reduction coupled reaction and then converts glycerol-3-phosphate back to 
dihydroxyacetone phosphate in a reaction coupled to the oxidation of FAD to form 
FADH2  [60, 61]. The Malate/aspartate shuttle (Figure 8) is made up of two antiporters, 
the malate/α-ketoglutarate antiporter and the glutamate/aspartate antiporter [61, 62]. 
In the cytosol, aspartate is converted to malate via oxaloacetate resulting in the 
oxidation of NADH to NAD+, the malate can then be transported across the 
mitochondrial membrane by the malate/α-ketoglutarate antiporter. Once in the 
mitochondrial matrix the malate is converted back to aspartate via oxaloacetate and 
NAD+ is reduced to generate NADH, the aspartate is transported back to the cytosol by 
the glutamate/aspartate antiporter [60]. These mechanisms have the overall effect of 
transporting electrons in the form of NADH or FADH2 into the mitochondrial space to 
enter the electron transfer chain as shown on the inner mitochondrial membrane in 
Figure 7 and thereby increasing the potential ATP generation from glycolysis [57]. 
Inhibition of both G3P and malate/aspartate shuttles in rodent beta cells severely 
decreases the glucose stimulated insulin secretion response [63] and decreased activity 




Figure 7. Diagram showing G3P shuttle and electron transfer chain. [61] 
 
 
Figure 8. Diagram showing malate/aspartate shuttle [60] 
32 
 
Anaplerosis is the process by which the intermediates in the TCA cycle are replenished 
and is necessary for the transfer of glucose derivatives through the TCA cycle. One of 
the most important anaplerotic reactions involves the conversion of pyruvate to 
oxaloacetate by pyruvate carboxylase (PC). Around 60% of glucose in beta cells is 
oxidised by pyruvate dehydrogenase to produce acetyl CoA whilst around 40% is 
carboxylated by PC [55]. Together these intermediates produce citrate which can enter 
the TCA cycle. PC activity is higher in beta cells than in most other tissues and its 
inhibition through either the addition of the inhibitor phenylacetic acid or small 
interfering RNA knockdown has been shown to inhibit GSIS [56, 65]. Mutations in the PC 
gene do not lead to a clinically detectable decrease in GSIS but its activity correlates with 
the glucose concentration beta cells are exposed to and the consequent insulin release 
[65]. At higher extracellular glucose concentrations PC is more active as the rates of 
metabolism increase and intermediates must be replenished at a higher rate [66].  
 
In most mammalian cells, pyruvate can also be metabolised by LDH to produce lactate 
which is transported across the plasma membrane by MCT but the expression of LDH 
and MCT in beta cells can interfere with glucose sensing. When LDH was overexpressed 
in INS-1 cells, insulin secretion could be stimulated at low lactate concentrations and 
MCT overexpression resulted in a 3.7-fold increase in lactate transport activity [54]. An 
increase in LDH activity would indicate a shift towards anaerobic metabolism meaning a 
loss in the tight coupling between glycolytic and mitochondrial metabolism required for 
maximal ATP production [54, 59, 67]. Uptake of lactate into the beta cell from the blood 
via MCT can stimulate inappropriate insulin release leading to hypoglycaemia.  The 
expression of LDH and MCT genes in beta cells is repressed during early postnatal islet 
maturation [55, 68] and Sekine et al reported that LDH activity was 100 fold lower in 
beta cells than in other cell types investigated in the same study such as lymphocytes, 




1.6. Cell Connectivity 
 
1.6.1. Cell Connectivity is Essential for GSIS 
 
Insulin secretion from beta cells is dependent on connections with adjacent cells. When 
islets are dispersed into individual beta cells, the insulin secretion response to nutrient 
stimulation is reduced. When beta cells are allowed to reaggregate they can form islet-
like structures known as pseudoislets that mimic the 3D architecture seen in the primary 
islets [70]. The insulin content does not differ between monolayer and 3D culture [71]. 
However, there is a greatly enhanced insulin secretory response in the pseudoislets [72]. 
Beta cell lines are often grown in monolayer culture which prevents the formation of 
the 3D architecture of islets seen in vivo but pseudoislets provide an ideal model for 
investigating the effect of homotypic connections on insulin secretion. The insulin 
secretion response is also higher in islets than in monolayer cultures when other 
stimulus is applied such as sulphonylureas, the KATP receptor stimuli carbachol or 
tolbutamide, and protein kinase activators [71]. The integrated insulin secretion 
response of the islet is greater than the sum of the responses of the individual beta cells 
suggesting that the 3D arrangement is necessary for an efficient insulin secretion 
response. If culture conditions are favourable beta cells will begin to reaggregate into 
3D structures over time in culture, if not, beta cells can adhere to plastic and outgrow. 
 
The improved insulin secretion response of islets is thought to be due to synchronisation 
of calcium oscillations. Beta cells within primary islets display synchronised oscillations 
in cytoplasmic Ca2+ concentration [73, 74]. The response of individual beta cells can vary 
greatly in the threshold for stimulation, the change in calcium concentration and the 
magnitude of the insulin secretion response [75]. If 3D structures begin to form, the 
insulin secretion response can be restored and the synchronisation of the amplitude and 
frequency of the cytoplasmic Ca2+ oscillations is regained [76, 77]. The cytoplasmic Ca2+ 
oscillations in beta cells that occur in response to glucose have been shown to be 
synchronised within islets whilst isolated beta cells do not display this synchronisation 
and have a much larger variability in the threshold for stimulation.  
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It has been reported that the decrease in insulin secretion response is immediate when 
islet or pseudoislets are dispersed. This shows that it is a result of short-term 
intracellular interactions rather than a change in the beta cell phenotype. However, it 
has also been demonstrated that connections between beta cells result in chronic 
changes to the cell proteome. Chowdhury et al used mass spectrometry and 
immunometric-based approaches to show that pathways involved in glycolysis, the TCA 
cycle, and oxidative phosphorylation were enhanced in beta cells cultured as 
pseudoislets when compared to those cultured in monolayer [78]. Phosphofructokinase 
(PFK) and pyruvate kinase were two of the proteins upregulated and showed a 2-fold 
and 4-fold increase in protein expression respectively in pseudoislets compared to 
monolayers. Both of these enzymes are involved in the glycolytic pathway with PFK 
being one of the key regulatory enzymes. PFK is also involved in the generation of 
rhythmic insulin oscillations [79]. All enzymes of the TCA cycle investigated were 
upregulated in pseudoislets, particularly citrate synthase, isocitrate dehydrogenase 
(ICD), and succinate dehydrogenase. Of the proteins involved in the oxidative 
phosphorylation pathway, 19 out of 22 were upregulated in pseudoislets. The 
enhancement of this pathway is supported by another study in which expression of 84 
genes involved in oxidative phosphorylation was quantified in monolayers and 
pseudoislets [80]. It was found that 76% of the genes showed at least a 1.4-fold increase 
in expression but the effect these changes have on glucose metabolism and insulin 
secretion was not investigated. The increased intercellular connectivity within 
pseudoislets was demonstrated by the increase in expression of proteins involved in gap 
junctions, tight junctions and adherent junctions.  
 
1.6.2. Pseudoislet Culture 
 
Due to the difficulty in retaining function in primary rodent beta cells and the scarce 
availability of human islets for use in research, most of the studies mentioned have used 
rodent derived insulinoma beta cell lines such as INS1, MIN6, RINm5F, and BRIN BD11.  
These cell lines have been shown to retain an insulin secretory response to glucose over 
prolonged culture periods. Three insulin secreting human beta cell lines have recently 
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been generated, but are still in the early stages of characterisation [81, 82]. The human 
cell line EndoC-βH1 shows improved GSIS when configured as pseudoislets [83].  
 
The preparation of pseudoislets requires culture on a surface with low negative charge 
to prevent adhesion of the cells to the surface. Ideal surfaces that have been shown to 
allow pseudoislet formation include ultralow adhesion plates [84] , gelatine coated 
plates [77], agarose gels [85] and PEG wells produced by contact photolithography [86]. 
Functioning pseudoislets produced by these methods have been used to generate 
valuable data but the consistency in islet size can be low and larger islets are prone to 
formation of necrotic cores. In an attempt to improve the quality of the pseudoislets, 
stirred suspension methods have been used by culturing the beta cells on an orbital 
shaker [86] or in a spinner flask [87]. This minimises the formation of pseudoislets that 
are too large and improves flow of nutrients to the cells, thereby preventing the 
formation of necrotic cores. Pseudoislets that have been produced in stirred suspension 
have been shown to have enhanced cell survival, propagation, and insulin secretion 
when compared to pseudoislets from static culture over a ten day culture period [88]. 
Pseudoislets can also be produced using a hanging drop method which involves the 
seeding of single drops containing a specified number of beta cells onto a culture dish 
which is then inverted for five to eight days [13]. The size of the pseudoislet can be 
controlled by changing the number of cells in the drop. The outcome was similar to that 
of the stirred suspension methods with smaller and more consistent pseudoislets. The 
hanging drop method is labour intensive but can be considered as a cheaper alternative 
to stirred suspension cultures when only small numbers of pseudoislets are required. 
 
Communication within islets occurs through autocrine and paracrine actions of 
hormones such as insulin, glucagon and somatostatin. Beta cells in islets are also linked 
directly by intracellular junctions, integrins, receptors, and cell adhesion molecules. 
Many of these connections have been implicated in the regulation of insulin secretion 




1.6.3. Cell-Cell Interactions 
 
i.  Cell Adhesion Molecules 
 
The cell adhesion molecule (CAM), N-CAM acts to maintain cell-cell interactions and may 
be involved in regulating beta cell proliferation [90]. The transmembrane CAM E-
Cadherin is present in the beta cell plasma membrane and forms calcium dependent 
homodimers with cadherins on neighbouring cells [1]. E-cadherin plays an important 
role in the formation of pseudoislets as shown by the culture of MIN6 in the presence 
of an E-cadherin antibody which inhibits the formation of pseudoislet structures [77]. 
The aggregation of beta cells is calcium dependent and can be reversed through culture 
in Ca2+ free media. The intracellular region of the E-Cadherin interacts with the actin 
cytoskeleton of the beta cell and contributes to the regulation of beta cell function and 
proliferation through coupling to the β-catenin/Wnt signalling pathway [77]. The 
aggregation of beta cells facilitated by E-cadherins enables other cell-cell interactions to 
form such as through connexins and EphA/Ephrin-As.  
 
ii. EphA-Ephrin-A system.  
 
EphA receptor tyrosine kinases and their Ephrin-A ligands are located on the plasma 
membrane of beta cells and are classified into A and B subclasses  [91]. Most EphAs bind 
to Ephrin-As and most EphBs bind to Ephrin-Bs activating either a forward or a reverse 
signalling pathway. When Ephrin-A-Fc-fusion proteins bind to EphAs the forward 
signalling pathway is activated resulting in inhibition of basal insulin secretion. The 
reverse signalling is activated when EphA-Fc-fusion proteins bind to Ephrin-As. This 
pathway is predominant in the presence of glucose and enhances glucose stimulated 
insulin secretion [1]. When beta cells are arranged in pseudoislets the ephAs and Ephrin-




Konstantinova et al discovered that EphAs are concentrated on insulin granules and are 
incorporated into the plasma membrane of beta cells during insulin secretion. The 
EphAs are then either phosphorylated at low glucose concentrations resulting in further 
inhibition of insulin secretion in a negative feedback mechanism or they are 
dephosphorylated under high glucose conditions favouring the reverse signalling 
pathway and increasing insulin secretion. It is proposed that the coexpression of EphA 
and Ephrin-A in β-cells is important for the regulation of the insulin secretion response 
[91]. A study by Jain et al showed that insulin secretion at high glucose concentrations 
could be further increased by the addition of small molecular weight Eph inhibitors  [6]. 
 
iii. Connexins  
 
A gap junction is formed when a connexon in the plasma membrane of a cell docks to a 
connexon of a neighbouring cell to form a channel that permits the transfer of small 
molecules up to 900 Da between cells. So far, 21 different connexin isoforms have been 
identified; these are expressed in varying proportions throughout different tissues in the 
body [92]. Connexons can dock with a connexon of the same isoform to form homomeric 
channels or with one made from different connexins to form heterotypic channels, this 
allows a large diversity of possible channels with varying properties. Connexin 
Figure 9. EphA-Ephrin-A bidirectional signalling between two β-cells [91] 
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hemichannels are involved in paracrine signalling, ATP, glutamate, NAD+, and 
prostaglandins. In neurons, connexins can increase rates of synaptic transmission and 
enable cells within excitable tissue to coordinate a synchronised response [93]. They 
also play a role in proliferation and apoptosis, and homeostasis in non-excitable tissue 
[92].  
The principal connexin isoform expressed in pancreatic beta cells, as well as neurons 
within the central nervous system, is connexin 36. Deletion of Cx36 in mouse models 
results in impaired function of neuronal and retinal cells and an increase in basal insulin 
secretion in the beta cells [94]. Evidence of other connexins within the islet has also been 
reported. Cx43 and Cx45 in mice, and Cx30.3, Cx31, Cx31.1, Cx31.9, Cx37, and Cx45 in 
human models. It is possible that these connexins form heterotypic channels with the 
Cx36 in beta cells aiding communication between the beta cells and vasculature or 
exocrine tissue [95].  
 
The synchronisation of the beta cell insulin response relies largely on connexin 36 (Cx36) 
gap junctions that provide electrical and metabolic coupling between cells. In the case 
of beta cells, the alignment of connexons relies on E-Cadherins. Gating of the Cx36 is 
controlled through a variety of environmental factors such as pH, the voltage across the 
channel, or the intracellular Ca2+. 
 
The importance of Cx36 in beta cells was first investigated by comparing monolayer and 
islet cultures since intercellular connexin channels cannot form between the isolated 
cells in monolayer. It was documented that beta cells that lack the intercellular 
connections displayed irregular Ca2+ oscillations that were not synchronised between 
beta cells and reduced overall GSIS indicating that the connections are essential for the 
optimal functioning of the beta cells [89]. This has since been confirmed in multiple 
studies both in vitro and in vivo through genetic Cx36 knockdown and reversibly blocking 
channels using lipophilic drugs [96]. Some studies have reported lower basal insulin 
secretion in beta cells connected by Cx36 channels than in isolated cells, this could be 
explained by the diffusion of Ca2+ ions throughout the beta cells allowing the less active 
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beta cells to prevent the more active cells from initiating an insulin secretion response 
at low glucose. However, the change in basal insulin secretion was not consistent in all 
studies with some reporting no increase in Cx36 deficient islets [95]. 
 
It has been shown that it is not necessary for all beta cells within the islet to be 
interconnected by Cx36 channels with an improvement in function detected when only 
two or three beta cells are connected and (fluorescence recovery after photobleaching) 
FRAP images have shown that not all neighbouring beta cells are connected but that 
connection patterns occur over long distances [97]. Overexpression of Cx36 may provide 
some protection against ER and oxidative stress and pro-inflammatory cytokines.  
 
Work by Squires et al suggests that intercellular communication via gap junctions is not 
solely responsible for the synchronisation of Ca2+ oscillations or the increase in insulin 
response [98]. MIN6 cells were cultured as monolayers or pseudoislets and gap junctions 
were blocked with the addition of either heptanol or 18-a-glycyrrhetinic acid (GA). The 
addition of heptanol at low concentrations resulted in a decrease in frequency of Ca2+ 
oscillations but the synchronisation of the oscillations between beta cells was not 
affected. Addition of GA, which has a higher potency in the uncoupling of gap junctions, 
decreased the amplitude of the Ca2+ oscillations. However, like the heptanol, GA did not 





Evidence suggests that efficient glucose stimulated insulin secretion in beta cells is 
dependent on both tight coupling between glycolysis and mitochondrial metabolism and 
through the maintenance of intercellular connectivity present in islets or pseudoislets. 
However, it is not clear if the cell connectivity influences the metabolic phenotype of 
the beta cell. The hypothesis of this study is that cell connectivity within islet structures 
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maintains the tight coupling between glycolysis and mitochondrial metabolism which is 




This thesis aims to explore the impact of cell connectivity on the metabolic 
characteristics of beta cells and determine the consequent impact on GSIS in both 
mouse and human models. The three main objectives are: 
1. To compare effects of 2D vs 3D culture on the metabolic function of beta cells. 
2. To determine whether any changes in function correlate with changes in the 
metabolic phenotype of the beta cells. 








All reagents were obtained from Sigma Aldrich unless otherwise stated. High range rat 
insulin ELISA kits were obtained from Mercodia (Uppsala, Sweden). Dulbecco’s modified 
eagle medium (DMEM), foetal bovine serum (FBS), penicillin-streptomycin, trypsin-
EDTA, sodium pyruvate, and Hepes buffer were obtained from Thermo Scientific 
(Paisley, UK). Magnesium chloride, glucose, Triton-X 100, sodium hydroxide, 
triethanolamine buffer, and EDTA were obtained from BDH Laboratory Supplies (Poole, 
Dorset, UK). MIN6 cells were kindly provided by Prof. J.-I. Miyazaki (University of Tokyo, 
Japan). 
 




i. MIN6 Maintenance 
 
Mouse insulinoma MIN6 cells (between passages 21 to 29) were cultured in 25cm2 and 
75cm2 cell culture flasks (Greiner Bio-one Ltd) in Dulbecco’s modified Eagle’s Medium 
(DMEM) containing 25mM glucose and 25mM HEPES and supplemented with 100mM 
pyruvate, 15% foetal bovine serum (FBS), 5µl/l β-mercaptoethanol, 75mg/l penicillin, 
50mg/l streptomycin and cultured in a humidified incubator at 37°C in 5% CO2. Media 
was replaced every 2 to 3 days and the cells were passaged when confluent using 
trypsin-EDTA.  
ii. MIN6 counting 
 
For counting, media was removed, and cells were washed twice with PBS, then 0.5ml 
trypsin-EDTA was added to a 25cm3 flask of confluent cells and incubated at room 
temperature for three to five minutes. Once cells had detached the suspension was 
transferred to a universal containing 5ml of media. A stock solution was prepared by 
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adding 5µl cell suspension to 45µl PBS. A glass coverslip was placed on a 
haemocytometer and 10µl of the diluted cell suspension was added to the coverslip. 
Cells were counted in the four corner squares and the centre squares and the number 
of cells was calculated using Equation 1. 




Equation 1. calculation for total number of cells per ml 
 
 
iii. MIN6 Experimental Culture 
 
The monolayer cultures were prepared by culturing MIN6 on either 6 or 24 well plates 
for five days. The seeding density used reflected the density used in the pseudoislet 
culture ranging from 5x103 to 5x105 cells/cm2. 
 
Pseudoislets were initially prepared by culturing MIN6 on 1% (wt) gelatin coated 6 well 
plates and petri dishes at seeding densities of 2.5x104, 2.5x105 and 2.5x106 cells/ml. To 
compare seeding densities MIN6 were then cultured in petri dishes at densities of 
2.5x104, 2.5x105 and 2.5x106 cells/ml or 3x103, 3x104, and 3x105 cells/cm2 respectively. 
All further pseudoislets were cultured on petri dishes for five to six days with an initial 
seeding density of either 4.3x105 cells/cm2 or 2.8x105 cells/ml. The media was replaced 
by carefully transferring the pseudoislets into a Falcon® 15mL polystyrene conical 
centrifuge tube, allowing the pseudoislets to form a pellet by gravity so that the media 
could be aspirated and replaced. The petri dishes were washed with (phosphate 
buffered saline) PBS and the pseudoislets in the fresh media replaced.  
 
2.2.2. Human Islets 
 
Human islets (LDIS247, LDIS248, and LDIS256) were isolated from three donors without 
diabetes at NHS Blood and Transplant, Barrack road, UK, with appropriate ethical 
approval. Table 2 shows Islet donor information. Islets were maintained in CMRL media 
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supplemented with 0.5% human albumin serum, 50μg/ml streptomycin and 50μg/ml 
penicillin. On receipt, Islets were given one day to recover from transportation before 
being used for experiments. 
Code Age Gender BMI Donor Type Purity 
LDIS247 48 F 32.49 DBD 80% 
LDIS248 49 F 26.63 DCD 82.5% 
LDIS246 53 M 25 DBD 80% 
Table 2. Islet Donor Information 
DBD = donor after brain death, DCD – donor after cardiac death 
 
2.3. Generation of Stable Inducible MIN6 Cx36 Knockdown Cell Line 
 
2.3.1. Lentiviral Promotor Selection 
 
The optimal promotor for transduction of MIN6 was selected using a SMARTchoice 
promotor selection kit. This kit allowed transduction of MIN6 with seven different 
promotors, hCMV, mCMV, hEF1α, mEF1α, PGK, and UBC. The most active promotor 
could be selected through assessment of visual intensity (SP-001000-01, Dharmacon).  
 
2.3.2. Transduction of Lentiviral Particles 
 
Three SMARTvector shRNA lentiviral constructs listed in table 3 were ordered containing 
the mCMV promotor and targeting Cx36 expression along with a non-targeting control 
(VSC6570).  
KD Catalogue Code Antisense Sequence Target 
1 V3SM7672-232247995 CGTAATTCCCTCTAGCTTG 3’ UTR 
2 V3SM7672-233160478 TAGAGTACCGGCGTTCTCG ORF 
3 V3SM7672-235462855 TTGATGCAGGGGTAACGGT ORF 
Table 3. SMARTvector shRNA Lentiviral Constructs 
 
On day one of transduction, a 96 well plate was seeded with P25 MIN6 cells at a density 
of 30,000 cells/well. On day two cells were transduced with the three constructs and the 
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control with anticipated functional titres of 2.5x106 TU/ml for the targeting constructs 
and an anticipated functional titre of 3x106 TU/ml for the control. The MIN6 and shRNA 
constructs were incubated with 8μg/ml polybrene in FBS free media for six hours. After 
six hours the transduction medium was replaced with MIN6 culture medium. On day 
four 1μg/ml puromycin was added for at least three days to select transduced cells. The 
shRNA expression was induced by addition of 1mg/ml doxycycline for 48 hours and 
transduction was confirmed by checking TurboGFP expression using fluorescence 
microscopy and through western blot analysis.  
 
2.3.3. Maintenance of Stable Cell Line 
 
The stable MIN6 cell line with inducible Cx36 knockdown along with another cell line 
transfected with a scrambled control were cultured in the same conditions as the MIN6 
with 1μg/ml puromycin added. Pseudoislets were generated by culturing the cells on 
petri dishes for five days. Puromycin was removed during pseudoislet formation. The 
knockdown was induced over the final 48 hours of the pseudoislet formation by the 
addition of 1µg/ml doxycycline on day three of pseudoislet culture.  
 
2.4. Islet Equivalent Counts 
 
Islet equivalent quotients (IEQ) were calculated where one islet equivalent is equal to 
an islet with a diameter of 150µm. The volume of media in each petri dish containing 
pseudoislets was measured and recorded as the pool volume. The pseudoislets were 
mixed by inverting and 100µl samples were transferred to a six well plate for counting. 
Counting was performed at 10x magnification on a microscope with a measuring grid in 
the eyepiece. The islets were measured and classified according to size and the totals 
were multiplied by an islet equivalent conversion factor. The total number of free islet 





2.5. Propidium Iodide Viability Staining 
 
A viability stain was prepared by adding 10µl of prodidium iodide dye (P1304MP, 
Thermo Fisher) and 1µl 10mM H33342 to 1ml of media. A sample of 100 pseudoislets 
(P21 to P25) was incubated in 500µl of the PI stain for 10 minutes at room temperature 
then the stain was replaced with fresh media. The pseudoislets were transferred to a 24 
well plate and imaged using light microscopy and fluorescence microscopy on a Nikon 
Eclipse TE2000-S. Images were analysed using CellProfiler software to calculate the 
percentage viability of each islet.  
 
2.6. Enzyme Activity Assays 
 
Enzyme activity assays were performed at 37°C in 96 well plates using the Spectramax 
plate reader (Molecular Devices) and analysed using Softmax pro software. Absorbance 
was read at 340nm every minute for 20 minutes unless otherwise specified. The enzyme 
activity is expressed as mU/mg protein.  
 
For each sample 500µl of extraction buffer was added to either one well of a 6 well plate 
for monolayer culture or 800 pseudoislets. The extraction buffer was prepared with 
150mM KCl, 3mM Hepes, 1mM dithiothreitol (DTT), 1mM Benzamidine, and 10µl PIC 
(P8340 Sigma Aldrich). Supernatant and cell pellet fractions were then separated by 
transferring half of each sample to a separate 1.5ml Eppendorf and centrifuged at 9000 
rpm (Harrier 18/80R) for five minutes. The supernatant was removed and saved, and 
the remaining pellet was resuspended in 400µl of the extraction buffer. The total cell 
homogenate, pellet and supernatant were then assayed individually. Enzyme 














Originally all enzyme activity assays were completed using earlier passage, P21 to P25 
MIN6. When data showed a trend towards changes in activity but did not reach 
statistical significance, these assays were repeated using higher passage MIN6, P26 to 
P29. 




Hexokinase (HK) and glucokinase (GK) activities were assayed by measuring the NADH 
production in the following reaction.  
Glucose + ATP    glucose 6-phosphate + ADP 
 
Glucose 6-phosphate + NAD       6-phosphogluconate + NADH 
 
Each sample was centrifuged at 9000 rpm (Harrier 18/80) in a 1.5ml Eppendorf and the 
supernatant transferred to a new Eppendorf. 80µl of each supernatant was pipetted into 
wells of a 96 well with 80µl of the main reagent containing 50mM Hepes (pH 7.8), 
100mM KCl, 2mM MgCl2, 6mM ATP/Mg2+, 1mM NAD, 2mM DTT, and 1.5U/ml glucose 
6-P dehydrogenase. A glucose concentration of 0.5mM was used to measure low Km HK 
activity and 50mM glucose to measure total HK activity. GK activity was calculated by 
the difference in activity between these two conditions.  
 
 
Equation 1. Equation based on the beer lambert law used to calculate the enzyme 
concentration (mU/mg).  c=enzyme activity concentration, A=absorbance, ε=molar 
extinction coefficient (NADH=6.22 and DTNB=13.6), l=path length (0.45 for 200μl 
sample, and 0.36 for 160μl sample), v=volume of initial cell suspension, DF=dilution 







Phosphoglucoisomerase (PGI) activity was measured by recording the NADH production 
in the following reaction. 
Fructose 6-phosphate                    Glucose 6-phosphate 
Glucose 6-phosphate + NAD    Glucose 1-phosphate + NADH 
 
Each sample was diluted 1:5 with the extraction buffer described above then 20µl was 
pipetted into a 96 well plate with 180µl of the main reagent containing 50mM Hepes, 
1mM MgCl2, 0.5mM NAD, 2mM fructose 6-phosphate, 1mM DTT, and 2.5U/ml glucose 




PFK1 activity was measured by recording the rate of oxidation of NADH in the following 
reactions. 
Fructose 6-phosphate  + ATP                       Fructose 1,6-bisphosphate  + Pi 
Fructose 1,6-bisphosphate                  Dihydroxyacetone phosphate + Glyceraldehyde 3P 
Glyceraldehyde 3-phosphate                     Dihydroxyacetone phosphate 
Dihydroxyacetone phosphate + H+ + NADH                Glycerol 3-phosphate + NAD+ 
For each sample, 20µl of the total cell homogenate was pipetted into a 96 well plate 
with 180µl of the main reagent containing, 20mM Tris, 100mM KCl, 2mM NH4Cl2, 3mM 
MgCl2, 1mM ATP/MgCl2, 0.16mM NADH, 2mM AMP, 10mM fructose 6-phosphate, 12µl 
α-glycerophosphate dehydrogenase-triosephosphate isomerase from rabbit muscle 













Aldolase activity was recorded by measuring the oxidation of NADH in during the 
following reactions: 
Fructose 1,6-bisphosphate               Dihydroxyacetone phosphate  +  Glyceraldehyde 3-P 
 
Glyceraldehyde 3-phosphate                     Dihydroxyacetone phosphate 
 
Dihydroxyacetone phosphate + H+ + NADH                Glycerol 3-phosphate + NAD+ 
 
For each sample, 20µl of the total cell homogenate was pipetted into a 96 well plate 
with 180µl of the main reagent containing, 20mM Tris, 100mM KCl, 0.32mM NADH, 
10mM fructose 1,6-bisphosphate, and 12µl α-glycerophosphate dehydrogenase-
triosephosphate isomerase from rabbit muscle (G6755, Sigma Aldrich). 
 
v Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
 
GAPDH activity was measured by recording the rate of oxidation of NADH during the 
following reactions: 
Glycerate 3-phosphate  +  ATP                 glycerate 1,3-bisphosphate  + ADP 
G1,3-P2 + NADH + H+                 Glyceraldehyde 3-phosphate + NAD+ + Pi 
For each sample 20µl of the sample to a 96 well plate with 180µl of main reagent 
containing, 0.1M triethanolamine (pH 8), 6mM glycerate 3-phosphate, 0.18mM EDTA, 













vi Pyruvate Kinase 
 
Pyruvate kinase activity was measured by recording the rate of oxidation of NADH during 
the following reactions: 
PEP  +  ADP          Pyruvate  +  ATP 
Pyruvate  +  NADH  +  H+       L-lactate  +  NAD+ 
 
Each sample was diluted 1 in 5 with the extraction buffer and 20µl of the total cell 
homogenate was pipetted into a 96 well plate with 180µl of the main reagent 
containing, 0.1M triethanolamine, 4mM phospho(enol)pyruvic acid (PEP), 4mM ADP, 
0.4mM NADH, 5mM MgSO4, and 5µl 25mg/ml LDH. 
 
vii Lactate Dehydrogenase 
 
LDH activity was measured by recording the rate of oxidation of NADH during the 
following reaction: 
Pyruvate  +  NADH  +  H+              L-lactate  +  NAD+ 
For each sample, 50µl of the total cell homogenate was pipetted into a 96 well plate 









2.6.2. Mitochondrial Enzyme Activity Assays 
 
viii Pyruvate Carboxylase 
 
PC activity was measured by recording the rate of oxidation of NADH during the following 
reactions: 
Pyruvate  +  ATP  +  CO2          Oxaloacetate  +  ADP  +  Pi 
 
Oxaloacetate  +  NADH  +  H+       malate  +  NAD+ 
Samples were assayed by adding 20µl of the sample to a 96 well plate with 180µl of main 
reagent containing 80mM Tris, 2mM ATP, 16mM Sodium pyruvate, 22mM KHCO3, 9mM 
MgSO4, 0.32mM acetyl CoA, 0.16mM NADH, and 10µl malate dehydrogenase L(MDH-
RO, Roche) 
ix Citrate Synthase 
 
Citrate Synthase activity was measured by recording the rate of TNB production during the 
following reaction: 
Acetyl CoA  +  OAA  +  H2O     Citrate  +  CoA-SH  +  H+  +  H2O 
 
CoA-SH  +  DTNB          TNB  +  CoA-S-S-TNB 
Samples were assayed by adding 20µl of the sample to a 96 well plate with 180µl of main 
reagent containing 50mM Tris (pH8), 0.3mM Acetyl CoA, 0.24mM oxaloacetate, and 
0.2mM DTNB. Absorbance was read at 412nm every minute for 20 minutes. 
 
x Isocitrate Dehydrogenase (NADP linked) 
 
ICD activity was measured by recording the rate of NADP reduction in the following reaction: 







Samples were assayed by adding 20µl of the sample to a 96 well plate with 180µl of main 
reagent containing 50mM KPi (pH 7.4), 10mM MgCl2, 2.5mM isocitrate, and 0.25mM NADP 
(94596). 
 
xi α-ketoglutarate Dehydrogenase 
 
α-ketoglutarate Dehydrogenase activity was measured by recording the rate of NAD 
reduction in the following reaction: 
α-ketoglutarate  +  NAD+ +  Co-ASH+ TPP           succinyl CoA  +  NADH  +  H+  +  CO2 
 
Samples were assayed by adding 40µl of the sample to a 96 well plate with 160µl of main 
reagent containing 100mM Tris (pH 8), 0.5mM NAD, 3mM MgCl2, 0.2mM Thiamine 
Pyrophosphate (TPP), 0.04mM Coenzyme A, 0.0025mM rotenone, and 5mM α-
ketoglutarate. 
xii Malate Dehydrogenase 
 
Malate dehydrogenase activity was measured by recording the rate of NAD reduction in 
the following reaction: 
Oxaloacetate  +  NADH  +  H+       malate  +  NAD+ 
Each sample was diluted 1:5 with the extraction buffer then 20µl of the sample to a 96 
well plate with 180µl of main reagent containing, 0.2M KPi, 0.2mM NADH, and 2.78mM 
oxaloacetate. 
 
2.7. Western Blotting 
 
MIN6 cells (P26 - P29) from each well of a confluent 6 well plate were extracted in 2ml 
of extraction buffer comprising of 100mM Tris-HCL pH 7.4, 100mm NaCl, 2mM EDTA, 
25mM NaF, 0.1% Triton X-100, 0.1mM Na3VO4, 1mM Benzamidine, 1:1000 dilution 





buffer (121.4 mM Tris (pH6.8), 1.94% SDS, 10% glycerol, 0.04% bromophenol blue, 4% 
mercaptoethanol) and heated to 100°C for five mins and 10-40μg of protein were loaded 
in the gels. The gels were either made from 10% resolution gel (10% acrylamide, 39mM 
Tris (pH 8.8), 0.1% SDS, 1mM Temed, 1.7mM APS) and stacking gel (3% acrylamide, 
0.217mM Tris pH 6.8), 0.05%  SDS, 1.7mM Temed and 2.6mM APS) or readymade gels 
were used (4-12% SDS-PAGE gels (Bio-Rad, Hertfordshire, UK). Gels were run at 90V 
while samples moved through the stacking gel then 180V for 45-60 mins.  
 
Proteins were then electro-transferred at 15V and 0.8 Amps from the gels to PVDF paper 
that had been pre-soaked in methanol. The Blot was then blocked in 5% milk for 1 hour 
then washed in TBST, TBST was composed of 25mM Tris (pH7.4), 144mM NaCl, 5ml/L 
Tween-20 (P1379, Sigma Aldrich). Blots were incubated with primary antibodies 
prepared in 0.5% milk overnight at 4°C, 1:200 (GLUT2 (NBP2-22218SS), 1:100 anti-
monocarboxylic acid transporter 1 (ab90582), 1:200 connexin 36/GJA9 (QG219843), 
1:200 anti-hexokinase 1 (sc-46695). The blot was then washed in TBST and incubated 
with the secondary antibody in a 1:2500 dilution with 0.5% milk for 1 hour at room 
temperature (ant-rabbit HRP (P0448) and anti-mouse HRP (P0260)). Bands were 
detected using enhanced chemiluminescence and quantified using image J. 
 
2.8. Glucose Stimulated Insulin Secretion Enzyme-Linked Immunosorbent 
Assay (GSIS ELISA) 
 
MIN6 (P21 – P29) were cultured for five days in 24 well plates for monolayer cultures 
and petri dishes for pseudoislet culture. On day five the monolayers and pseudoislets 
were washed in Krebs-Hepes buffer containing 119mM NaCl, 4.74mM KCl, 2.54mM 
CaCl2, 1.19mM MgCl2, 1.19mM KH2PO4, 25mM NaHCO3, 10mM Hepes (pH 7.4), and 0.5% 
bovine serum albumin (BSA). The petri dish was washed in phosphate buffered saline 
and the pseudoislets were replaced in 7ml of the Krebs-Hepes buffer with 0.5mM 
glucose. Both the pseudoislets and the monolayers were incubated in the 0.5mM buffer 
for 30 minutes at 37°C then washed twice in the glucose free buffer. Approximately 200 
pseudoislets were transferred to each well of a 24 well plate and incubated along with 
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corresponding monolayers for a further hour in Krebs-Hepes buffer containing either 
5mM glucose or 25mM glucose. The supernatant was removed, and the insulin content 
measured using a high range rat insulin ELISA kit. The remaining cells were washed in 
PBS and extracted into 0.05% Triton-X 100 so that the protein concentration could be 
calculated through a Bradford assay and used to normalise the insulin activity. 
 
2.9. Protein Quantification using the Bradford Method 
 
Cells extracted for western blotting, enzyme activity analysis and GSIS ELISAs were 
diluted in 0.05% Triton X-100 solutions and sonicated for 20 seconds. The protein 
content was calculated using the Bradford method. 200μl of 1:5 v/v Biorad reagent 
(#5000006, Biorad) was added to 10μl of each sample as well as to 10μl samples of 
protein standards at 25, 50, 100, 150, 200, 300, and 500μg/ml in a 96 well plate. The 
plate was assayed on a plate reader using end point assay at 595nm. The concentrations 
of samples were calculated against the standard curve using Microsoft excel.  
 
2.10. Metabolic Analysis  
 
2.10.1. Seahorse XFe96 Analyser  
 
The seahorse bioanalyser requires a microplate in which cells or 3D structures are plated 
and a cartridge in which drugs and compounds to be injected into the plate are loaded 
[100]. The cartridge contains wells for four different injections to be preloaded and 
injected over the course of the experiment into each well. It also has a probe which sits 
above the samples with two sensors, one to measure pH and one to measure O2 
concentration. 
 
MIN6 monolayers (P26 – P29) were seeded onto plates five days before the assay. 
Pseudoislets were formed over five days in a petri dish then transferred to a spheroid 
microplate. Monolayers were seeded at a density of 1x104 cells/well onto a XF96 cell 
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culture microplate the day before testing. The pseudoislets were placed in XFe96 
spheroid microplates. The wells of the spheroid plate were first coated with cell-takTM 
(Corning) in 0.093mM NaHCO3 pH8 and incubated at 37°C for 20 minutes before washing 
in distilled water. One pseudoislet was then placed in the centre of each well with 180μl 
culture media and the plate was centrifuged at 200g for one minute to aid attachment.  
On the day before the assay, the cartridge was hydrated by filling each well of the utility 
plate with 200μl of XF calibrant (100840-000, Agilent) ensuring each sensor of the 
cartridge is submerged then incubated in a non-CO2 incubator overnight. On the day of 
the assay, the media on the assay plates was replaced with either mitochondrial stress 
test base media (103015-100, Agilent) containing 10mM Glucose, 1mM sodium 
pyruvate and 2mM L-glutamine or glycolysis stress test medium (103020-100, Agilent) 
containing 0.5mM glucose and 2mM L-Glutamine and the plate was incubated for one 
hour in a non-CO2 incubator. During the incubation, the injections were prepared and 
loaded into the cartridge. For measurement of the extracellular acidification rate (ECAR), 
injections were 200mM glucose, 20μM oligomycin then 500mM 2-DG. For measurement 
of the oxygen consumption rate (OCR), the injections prepared were 20μM oligomycin, 
5μM FCCP, then 5μM rotenone and antimycin A. These solutions are 10 times the final 
concentrations achieved once the compounds are injected into the well.   
 
2.10.2. Seahorse XFe24 Analyser  
 
Monolayer plates were set up as they were for the XFe96 but using 24-well plates 
instead of 96-well plates. Initially seeding densities of 60,000, 80,000, and 100,000 cells 
per well were used then 80,000 cells per well were plated in each subsequent 
experiment. Around 300 pseudoislets were placed in the centre of each well (excluding 
blanks) of a seahorse islet capture plate and an islet capture screen was placed on top 
of each sample. Plates were incubated in the seahorse base described in the previous 
step for one hour prior to incubation. Compounds injected for both OCR and ECAR 
measurements were glucose, oligomycin, FCCP, and antimycin A. Protein was then 
extracted in 0.05% Triton-X 100 so that the protein concentration could be calculated 
through a Bradford assay and used to normalise readings. ATP from oxidative 
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phosphorylation = OCRbasal – OCRoligo where OCRbasal is the OCR measured after the 
respiration of the MIN6 has reached equilibrium after addition of glucose and OCRoligo is 
the minimum OCR after addition of oligomycin. ATP from glycolysis = ECARtot/BP – (10 
(pH-pK1) /(1+10 (pH-pK1) ))(max H+/O2)(OCRtot – OCRAA) where ECARtot/BP is the total 
cellular ECAR divided by the buffering capacity of the media and OCRtot – OCRAA is the 
remaining OCR after mitochondrial metabolism is blocked by the addition of the 




RNA was extracted from MIN6 samples (P26 – P29) using a High Pure RNA Isolation kit 
(Roche, 11828665001). To quantify the RNA, 2µl of each sample of the sample was 
added to 100µl of distilled water and RNA standards were prepared at 5, 10, 20, 40, and 
50µg/ml. The samples and standards were pipetted in 100µl volumes onto a UV 
microtitre plate and absorbance was measured at 260nm by a spectramax plate-reader. 
Then cDNA was synthesised from 0.5μg RNA made up to 9μl with distilled water and 
treated with 2μl of 50µM random hexamers and incubated for 10 minutes at 70°C. the 
RT mix was prepared containing 4μl MMLV buffer, 0.5μl MMLV, 0.5μl 10mM dNTP mix 
and 4μl water per sample. From this mix, 9μl were added to each sample and this was 
incubated at 37°C for 50 minutes followed by 70°C for 15 minutes.  
 
Taqman based real time RT-PCR was performed using 18μl of taqman mix with 2μl of 
either H2O blank, RNA control, cDNA standard or sample. Primer sequences are listed in 
4. Relative mRNA levels were calculated from Δ cycle thresholds and corrected for the 







Gene Gene Symbol Species Transcript detected 










Ribosomal Protein Lateral 






Table 4. Primer Sequences for RT-PCR 
 
2.12. Statistical Analysis 
 
All statistical analysis was carried out on GraphPad Prism 6 software. The mean and 
standard error mean were calculated in each case and means were compared using a 
paired t test to test for significance at P<0.05, n numbers are representative of number 
of experiments.  
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Loss of functional beta cell mass is central to the development of both type 1and type 2 
diabetes. One indicator of good beta cell function is the insulin secretion response under 
basal and stimulating levels of glucose. Many independent investigations have shown 
that increasing cell-cell contacts improved glucose stimulated insulin secretion (GSIS) 
from beta cells in human and rodent models, in both primary cells and cell-lines [14, 76-
78, 83, 88, 89, 101-103]. However, the specific pathways that lead to the improved 
response are unknown. From further studies, it is known that appropriate GSIS relies on 
ATP production in response to nutrients, particularly glucose[11, 43, 51, 67]. However, 
whether improved cell-cell interactions alter metabolic flux and/or ATP production by 
beta cells has not been examined. In this study the influence of cell to cell connections 
on metabolic function in the MIN6 pancreatic beta cell line will be assessed. 
 
One way to introduce intracellular connections between beta cells is to allow the cells 
to aggregate in solution to form 3D structures known as pseudoislets as described in 
section 1.5.2. A variety of culture methods have been used to allow the pseudoislets to 
form (Figure 10), they have been grouped into four different methods. The culture 
duration, seeding density used, cell passage number, and resulting islet size for some 
studies utilising these methods are collated in table 5 where available. The most 
common method used is static culture on surfaces which prevent attachment either by 
applying a coating with a low static charge or using pre-treated wells that are 
commercially available [77, 84-86, 104]. Stirred suspension methods are also common, 
this involves agitating the cells throughout the culture to maintain them in suspension 
[88, 105]. It has been suggested that these stirred suspension techniques result in 
smaller, more consistent, islets forming. Smaller islets may be advantageous as this 
could reduce the occurrence of necrotic cores within the pseudoislets as nutrients have 
a smaller distance to travel as they diffuse to the innermost cells. Other methods include 
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the “hanging drop” technique and co culture with other cells such as endothelial cells. 
Since the hanging drop technique is labour intensive and will not produce the number 
of islets needed for this study, this method will not be investigated further [106]. 
 
Once the pseudoislets have formed, the function of the beta cells in the pseudoislet 
structure in response to glucose can be assessed by investigating the amount of insulin 
secreted in response to glucose stimulation. This is known as the glucose stimulated 
insulin secretion (GSIS) response. The comparison of the GSIS of MIN6 pseudoislets to 
the GSIS of MIN6 cultured as monolayers can give an indication of how the formation of 
the 3D structure influences beta cell function in response to glucose. 
 
3.2. Aims 
The aim of this chapter was to optimise a method for pseudoislet formation, a 
combination of static and stirred suspension culture technique were used. The viability, 
size and function of the resulting pseudoislets was recorded by a variety of methods. 
Objectives 
 
1. Determine the optimal conditions for culture of MIN6 as pseudoislet structures. 
2. Compare static vs stirred culture of pseudoislets. 
3. Assess the impact of pseudoislet formation on beta cell function compared to 
monolayer culture.
Figure 10 – Pseudoislet preparation methods described in current literature 
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Cell Type Seeding density Passage Islet size Comments 
Gelatin coated wells 
[107] 
















Control 88µm ± 
49 
Aggregates 
containing 1000 cells 
were unstable. 
PEG microwell [109] 5 days MIN6 3x106 cells/mL (x2)   
Incubated on an 
orbital shaker for at 
least 2 hours 
Ultra-low attachment 





2 x 105 cells per well on 
6 well plate. 
 





 1.1B4 Cells 
1 x 105 per well on 6 
well plate 
25-35   
ProCulture spinner 
flask [87] 
2 weeks (PIs in 
static didn’t grow 
after 8 days) 
MIN6 2-5 x 104 cells/ml 25-40 100-200µm  
Shaking culture [88] 10 days RIN5F    
reciprocal shaker at 
70rpm for up to 10 
days 
Table showing how pseudoislet production methods vary between studies using different culture methods. Pseudoislets are produced from 
the MIN6 mouse pancreatic beta cell line unless otherwise specified.  
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3.3. Selection of optimal surface for MIN6 pseudoislet formation 
 
First, the ideal seeding density and culture surface for the formation of pseudoislets was 
determined, initial densities investigated were based on the ranges of densities used 
previously as reported in table 3. A culture period of five days was selected as 
preliminary data in the lab deemed five days to be optimal to achieve an improvement 
in GSIS without development of a necrotic core and this culture period had been used 
in previous studies [78, 86]. MIN6 were cultured at seeding densities of 2.5x104, 2.5x105 
and 2.5x106 cells/ml on standard tissue culture 6 well plates, 6 well plates coated with 
(1% Wt/Vol) gelatin, and low adhesion petri dishes for five days. Images in Figure 11 
show that cells on the standard 6 well plate formed a monolayer particularly at the 
higher seeding density. Cells in the gelatin coated wells formed pseudoislets with the 
most consistently sized islets forming at the middle density. However, the pseudoislets 
began to attach to the gelatin coated wells making extraction of intact pseudoislets 
difficult and the pseudoislets at the higher density began to fragment. Free floating 
pseudoislets formed in the petri dish and the middle density also seemed to produce 
the most consistent islets. The islets at the higher density varied greatly in size and the 






   
   
Figure 11. Images of Monolayer and Pseudoislet Formation on Various Surfaces 
 
3.4. Selection of seeding density for optimal pseudoislet diameter 
 
As the MIN6 seeded in the petri dish seemed to form the best islets in the initial culture 
all future pseudoislets were cultured in petri dishes. To further investigate the optimal 
seeding density, MIN6 were cultured for five days in petri dishes at seeding densities of, 
1.4x105, 2.9x105, and 4.3x105 cells/ml. Islets can vary in size and shape so islet equivalent 
counts (IEQs) provide a method of standardising measurement of these islets relative to 
a standard islet of 150μm. Islets around the standard islet measurement are preferable 
1A 2A 3A 
1B 2B 3B 
1C 2C 3C 
Light microscope images at 10x magnification of MIN6 cultured for 5 days on A) a 6 well 
plate, B) a gelatin coated 6 well plate and C) a low attachment petri dish each at densities 





as islets smaller than this are likely to be fragments of islets that haven’t formed properly 
and as islet size increases above 150μm the risks of necrotic cores increases. The IEQ 
counts show that as the seeding density increased the diameters of the pseudoislets 
became more varied with islets over 251μm in diameter being formed at the highest 
density (Figure 12).  
 
Next the viability of the pseudoislets at the three seeding densities was determined. A 
propidium iodide stain was used to identify dead cells (red) and a Hoechst 33342 stain 
to identify all cells (blue) (Figure 13). For each image the percentage area covered by red 
or blue was calculated using CellProfiler so that the percentage viability for pseudoislets 
at each density could be calculated (Figure 14). The highest percentage viability was 
seen in the islets cultured at an initial seeding density of 2.9x105 cells/ml (Figure 15). At 
densities higher than this, the viability began to decrease and the variability between 
viability of islets began to increase. A seeding density to be used to produce pseudoislets 
in this study was selected based on the highest percentage viability and most desirable 
range of islet size, between 100 and 200μm. The seeding density of 2.9 x105 cells/ml 
with a percentage viability of 84% was selected. Due to the limitations of fluorescence 
microscopy, calculations were made based only on signal from surface of the islet and 
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Figure 12 - IEQ counts of MIN6 cultured for 5 days in low attachment petri dishes at 








A B C 
Images at 10x magnification of pseudoislets after five days of culture and stained 
with Propidium iodide (red) and Hoechst stain (blue). Cultures were prepared with 







Figure 14 – Image Processing using Cell Profiler 
Example of Image processing steps used to calculate percentage viability of 
pseudoislets using cell profiler. First calculating the % area covered by live cells 
shown using a Hoescht stain then the percentage area covered by dead cells using a 
propidium iodide stain. 
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Figure 15. Seeding Density influence on Pseudoislet Viability 
 
3.5. Comparison of static or stirred suspension culture methods for 
Pseudoislet formation 
 
Previous studies have reported that pseudoislets cultured in stirred suspension display 
improved viability and consistency in size to those cultured in a static system [88, 105]. 
Preliminary data in the laboratory deemed five days to be optimal to achieve an 
improvement in GSIS without development of a necrotic core, this culture period has 
also been used elsewhere [80]. To compare pseudoislets formed in each culture system 
and to determine whether a stirred suspension culture system would be beneficial, 
MIN6 were cultured for either five days on static culture or two days of static followed 
by three days of stirred suspension on an orbital shaker. The IEQ counts show that in 
this case the pseudoislets that formed in static culture were smaller and more consistent 
in size than those in stirred suspension (Figure 16). The viability of pseudoislets was then 
compared with a propidium iodide and Hoechst stain (Figure 17). The islets produced 
through just static culture were mostly between 100 and 200μm in diameter which is 
accepted in this study as the optimal size (Figure 16). The viability of islets from both 
Percentage viability of pseudoislets cultured for five days at 3 different initial seeding 
densities. Calculated using a propidium iodide stain to identify dead cells and a 
Hoechst stain to identify viable cells. Mean ± SEM N=5 
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culture systems was similar with a high proportion of viable cells. Stirred culture offered 
no improvement in viability and unfortunately did not produce consistently sized 
pseudoislets so static culture was used for the formation of pseudoislets for the 
remainder of the study. 
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Figure 16 - IEQ counts of MIN6 cultured for five days in either stirred suspension 







Figure 17. Pseudoislet Viability Images of Static Vs Stirred Culture 
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Figure 18. Pseudoislet Viability in Static Vs Stirred Culture Methods 
1A 2A 
1B 2B 
Propidium iodide (red) and Hoechst stain (blue) to show viability of pseudoislets 
cultured in A) static culture and B) stirred suspension for five days. Images are 
taken at 1) 10x and 2) 20x magnification. 
 
Percentage viability of pseudoislets cultured for either five days in static culture or 4 
days in static plus one day in a stirred suspension. Calculated using a propidium iodide 
stain to identify dead cells and a Hoechst stain to identify viable cells. Based on one 




3.6. Impact of pseudoislet formation on insulin secretion 
 
3.6.1. Optimisation of GSIS measurements for Pseudoislets 
 
To confirm that pseudoislet formation increased the glucose stimulated insulin secretion 
response as described in previous studies [65], insulin secretion was measured at 3mM 
glucose and 16.7mM glucose. To test this, we incubated pseudoislets and monolayers in 
media without glucose for 30 minutes and then stimulated with 3mM versus 16.7mM 
glucose for 1 hour. However, the results showed that the insulin secretion was higher at 
3mM glucose than at 16.7mM glucose, particularly in the pseudoislet cultures (Figure 
19). This may be because the cells at the lower glucose concentration were releasing 
insulin under stress, to avoid this the glucose concentrations used were altered.  
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Figure 19. Initial GSIS Measurements 
 
Instead of starving the MIN6 before glucose stimulation, samples were incubated in 
either 0.5mM or 3mM glucose for 30 minutes. The insulin secretion response was 
Insulin secretion response of MIN6 (P21-P25) cultured as either monolayers or 
pseudoislets for 5 days and incubated for 30 minutes in glucose free media then 1 









stimulated by one hour of incubation at either 3mM, 5mM, 16.7mM, or 25mM glucose 
(Figure 20). There was no difference between samples incubated at the initial 
concentration of 0.5mM or 3mM glucose. The basal insulin secretion was lower at 5mM 
glucose than at 3mM glucose. Incubation at both 16.7mM and 25mM glucose increased 
insulin secretion with the 25mM glucose concentration stimulating the highest 
secretion. In future assays, islets will be preincubated at 0.5mM glucose and 5mM and 
25mM glucose concentrations will be used to compare non-stimulating and stimulating 
conditions. 
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Figure 20. Optimising Glucose Concentration for GSIS. 
 
3.6.2. Effect of Seeding Density on Insulin Secretion 
 
The insulin secretion response measured was still not optimal so the effect of using 
different seeding densities when setting up the pseudoislet cultures was investigated. 
The seeding densities used when plating the MIN6 for pseudoislet formation were 
1.4x105 cells/ml, 2.8x105cells/ml, or 4.2x105 cells/ml. Insulin secretion was measured 
Insulin secretion response of MIN6 (P21-P25) cultured as pseudoislets for 5 days and 
incubated for 30 minutes at either 0.5mM or 3mM glucose then 1 hour at either 








during incubation with 5mM glucose and 25mM glucose. There was no difference in 
insulin secretion response between the monolayers and pseudoislets formed from any 
of the three cell densities (Figure 21). The viability was highest in the pseudoislets 
seeded at the middle density, 2.8x105cells/ml so this is the density that will be used in 
future experiments.  
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Insulin secretion response of MIN6 (P21-P25) cultured as monolayers or 
pseudoislets with one of 3 different initial seeding densities for 5 days and 
incubated for 30 mins in 0.5mM Glucose media then 1 hour at either 5mM glucose 








3.6.3. Effect of cell passage on insulin secretion 
 
MIN6 cells have been characterised as stable for 30 to 40 passages but the GSIS response 
tends to decrease beyond P30 [111]. This loss is associated with changes in gene 
expression, protein levels and metabolism [7]. The high passage MIN6 cells display 
decreased glucose uptake and oxidation resulting in reduced ATP levels in cells under 
high glucose [112]. Due to the loss of responsiveness of the older MIN6 monolayers, the 
influence of passage number on basal insulin secretion was determined. A comparison 
of insulin secretion response in MIN6 monolayers at low and high passage numbers, 
defined as <P26 and >P26, respectively, showed a significantly higher basal insulin 
secretion in the high passage cells (Figure 22). Low passage ranged from P22 to P25, 
whilst high passage ranged from P26 to P29. The glucose responsiveness was impaired 
in the higher passage cells with low passage displaying a 3.5-fold increase in insulin 
secretion and high passage displaying only a 1.6-fold increase. This was also shown by 
plotting the basal insulin secretion against passage number, here there is a clear 
upwards trend in basal insulin secretion with passage number (Figure 23). The basal 
insulin secretion response of pseudoislets was not influenced by passage number but 






Figure 22. MIN6 Monolayer Insulin Secretion at High and Low Passage 
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Figure 23. Monolayer Basal Insulin Increase with Passage Number 
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Basal insulin secretion of MIN6 (P21-P29) cultured as monolayers and incubated for 
30 minutes at 0.5mM glucose then 1 hour at 3mM glucose N=13 (R2=0.3675, P=0.02, 
linear regression) 
Insulin secretion response of MIN6 cultured as monolayers for 5 days then 
incubated in 0.5mM glucose for 30 minutes before being exposed to low glucose 
≤5mM or high glucose ≥16.7mM. N=7 for low passage (P21-P25), n=6 for high 
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Figure 24. MIN6 Pseudoislet Insulin Secretion at High and Low Passage 
 
 
3.6.4. comparing glucose induced insulin secretion in 2D vs 3D Structures 
 
Once it had been established that changes in function between 2D and 3D structures 
are more obvious at higher passages when the beta cells begin to function less 
efficiently, GSIS was assessed in monolayer and pseudoislet MIN6 using only higher 
passage cells, P25-P28. The monolayers showed no significant increase in insulin 
secretion between low glucose and high glucose but a significant increase in insulin 
secretion was seen between pseudoislets at low glucose and high glucose (P<0.001) 
(Figure 25). The pseudoislet increase in insulin secretion was 7.4-fold whilst the 
monolayers were much less responsive showing only a 1.5-fold increase in insulin 
secretion. The basal insulin secretion may be slightly higher in monolayers, but this is 
not statistically significant.  
Basal insulin secretion of MIN6 (P21-P29) cultured as pseudoislets for 5 days and 
incubated for 30 minutes at 0.5mM glucose then 1 hour at low glucose ≤5mM or 
high glucose ≥16.7mM. N=5 * P<0.03 
74 
 







G S IS  R e s p o n s e  in  M o n o la y e r
















5 m M  G lu co se




Figure 25. GSIS Response in Monolayer Vs Pseudoislet MIN6 
  Insulin secretion response of MIN6 (P25 to P29) cultured as either monolayers or 
pseudoislets for 5 days and incubated for 30 minutes in 0.5mM glucose media then 
1 hour at either 5mM glucose or 25mM glucose. N=5,  * = p<0.005,   ** = p<0.001. 








3.7.1. Pseudoislet Formation 
 
The first aim of this investigation was to develop a protocol to produce pseudoislets that 
were consistent in size, viability and function. Review of previous studies utilising 
pseudoislets showed that the methods currently used to produce pseudoislets vary and 
so different culture methods and seeding densities were compared to determine the 
optimal method for producing consistent pseudoislets. In most studies pseudoislets 
were formed over five to eight days on either a non-adhesive tissue culture plate [84] or 
in gelatin coated wells [77] and seeding densities ranged from 2x104 cells/ml [105] to 
1x105 cells/ml [84]. 
 
In this study it was found that MIN6 cultured in gelatine coated wells and in petri dishes 
both aggregated to form pseudoislets but in the gelatine coated wells the pseudoislets 
began to attach to the bottom of the well after the first day. Therefore, petri-dishes 
were used for the remainder of the study. The ideal islet size to be used in this study is 
between 100 and 200μm based on the average diameter of a native islet being 150μm 
[8]. Approaches to optimise seeding density showed that many of the pseudoislets 
formed at the lowest density (1.4x105 cells/ml) were small, below 100µm in diameter, 
and often fragmented whilst pseudoislets formed at the highest seeding density 
displayed a much greater range in size but also showed lower viability. This may be 
because the larger islets, particularly those over 200µm in diameter, developed necrotic 
cores due to the restricted flow of nutrients to the cells in the centre of the islet. The 
middle seeding density of 2.9x105 cells/ml produced the pseudoislets with the highest 
viability and the lowest variability in size with most islets being between 50 and 200 µm 
in diameter. The insulin secretion response of pseudoislets formed from MIN6 seeded 
at the three densities was also measured and it was found that seeding density had no 
influence on insulin secretion response when the cells were at a low passage number 
but at a higher passage number the response of pseudoislets from the highest seeding 
density was lower. From these findings the seeding density of 2.9x105 cells/ml in petri 
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dishes was selected as the optimal conditions for static culture, this was similar to the 
seeding density used by Bernard, 2012 [86]. 
 
Some studies have suggested that over prolonged culture, stirred suspension culture 
systems offer tighter control over cluster sizes and improved transfer in metabolites, 
which may maintain the viability of the cells [105]. In this study, pseudoislets were 
formed over 5 days either on continuous static culture or with stirred suspension for the 
final 2 days. There was no change in the size and viability of the pseudoislets on day 5 
suggesting that over 5-day culture, stirred suspension doesn’t offer any benefit. Other 
studies reporting improved viability with stirred suspension were cultured over longer 
time periods, up to two weeks [105]. It may be that there was less clustering of fully 
formed islets in the stirred suspension system, but this was not quantified. Propidium 
iodide staining showed that the stirred suspension offered slightly more consistency in 
viability but not enough to outweigh the benefits of the islet size distribution offered by 
the static culture. The static culture system showed viability of more than 80% and so 
provided a good model for the formation of all further pseudoislets used in this study. 
 
3.7.2. Passage Number Influences Insulin Secretion 
 
At low passage number, <P26, the monolayers displayed good GSIS that was similar to 
the GSIS seen in pseudoislets. However, at high passage number, >P26, the GSIS 
response in monolayers was less efficient. Basal insulin secretion was higher and the 
increase in insulin secretion at high glucose compared to low glucose was small, this is 
similar to the functional phenotype in models of T2DM [20, 113]. Using both in situ tissue 
technology and acute human pancreas specimens, Cohrs et al showed that functional 
deterioration occurred in beta cells during early stages of T2DM before stages where 
loss of beta cell mass was observed [114]. This deterioration in function included an 
increase in basal insulin release and a loss in first phase insulin release. Function declined 
further as the pathogenesis as T2DM progressed with the second phase insulin secretion 
beginning to also decline. In another study, dynamic parameters of beta cell function 
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were measured in 188 individuals (19 lean NGT, 42 obese NGT, 22 IGT, and 105 
T2DM)[115]. The parameters included glucose sensitivity, rate sensitivity, and 
potentiation. They showed that impaired glucose sensitivity began in the early stages of 
IGT and beta cell function continued to decline through progression to T2DM.  
Longitudinal studies involving Pima Indians indicated that both insulin secretion and 
insulin action significantly decrease early in the development of T2DM [116], and that a 
high fasting plasma insulin concentration is predicative of T2DM [117]. Pseudoislets 
showed an improved GSIS response compared to monolayers which was only evident at 
a higher passage number. Hauge-Evans et al also report that differences in function 
between monolayers and pseudoislets become more obvious at higher passages, P43-
P53 [77]. Studies reporting that pseudoislets display a superior insulin secretion 
response compared to monolayers do not always include the cell passage number or 
include a large range of passage numbers (P20-P35 [104], P25-P40 [105]). This means 
the effect of passage number on insulin secretion is not clear. It is possible that at low 
passages the function of the beta cells is already optimal and cannot be improved by 
arranging the cells as pseudoislets so differences in insulin secretion response between 
pseudoislets and monolayers only becomes clear in older cells to drop. This is only 
relevant to the MIN6 system as changes have been shown in dispersed versus 
reaggregated rodent islets [16]. 
 
3.7.3. Pseudoislet Formation Appears to Improve Insulin Secretion Response 
 
Once the insulin secretion assay was optimised, our studies showed that pseudoislets 
offered an improved insulin secretion response similar to that shown in previous studies. 
There is a large increase in insulin secretion in the pseudoislets with glucose stimulation 
from 0.4 to 3µg/µl but only a slight increase is seen in the monolayers (0.6 to 0.8 µg/µl). 
It appears that the basal insulin secretion was slightly higher in monolayers than in 
pseudoislets, although this did not reach statistical significance. Previous studies have 
also shown that basal insulin secretion is higher in cells lacking connections through 
either dispersion, monolayer culture or Cx36 knock down [70, 118]. It is important that 
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basal insulin secretion is low to prevent inappropriate insulin secretion in the absence 
of glucose so this increase could indicate a less efficient insulin secretion pathway [53].  
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It has been shown, both in previous literature [14, 76-78, 83, 88, 89, 101-103] and using 
the pseudoislets formed in this study, that beta cells arranged as a 3D structure display 
a greater insulin secretion response to glucose than beta cells cultured in monolayer. As 
a good insulin secretion response relies on optimal metabolism through the glycolytic 
and mitochondrial pathways [57] it is of interest to investigate differences in metabolic 
function between the two culture systems. It is known that an optimal insulin secretion 
response relies on the beta cells displaying a specific metabolic phenotype. This 
metabolic phenotype is discussed in section 1.4.2. but in summary involves tight 
coupling between glycolytic and mitochondrial metabolism [53] with low expression of 
hexokinase-1, lactate dehydrogenase, and monocarboxylate transporters [54, 55]. This 
phenotype exists to optimise ATP production from glucose metabolism to ensure a 
robust GSIS response from beta cells. 
 
The oxygen consumption rate of islets has been measured using Clark oxygen electrodes 
and using Seahorse XF Bioanalysers [100, 119-121]. Oxygen consumption rate is directly 
linked to the flow through the electron transport chain and therefore ATP produced in 
the mitochondria. High oxygen consumption rates in islets have been shown to improve 
transplant efficacy [122]. However, proton leak across the mitochondrial membrane 
leads to some oxygen consumption which is not linked to ATP production. A high level 
of proton leak in beta cells indicates a lower bioenergetic efficiency. Wilkstrom et al 
compared the extent of mitochondrial proton leak in the rat insulinoma cell line, INS-1, 
and islets from both mouse and human donors.  This study used oxygen consumption 
rate in the presence of oligomycin and FCCP to calculate the rate of proton leak as a 
percentage of basal respiration. They reported that mouse islets displayed the highest 
levels of proton leak, between 50 and 60% whilst INS-1 cells and human islets from both 
diabetic and non-diabetic donors all displayed around 38% proton leak, a significantly 
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lower amount than the mouse islets. This highlights possible differences in the 
bioenergetic profile of mouse and human islets [123]. Investigation into the stimulation 
of human islets by four different fatty acids showed 1.1 to 1.5 fold increases in OCR and 
1.2 to 1.6 fold increases in ECAR when compared to basal rates [124]. The metabolic 
phenotype of insulin producing human embryonic stem cell derived beta cells (SC-β) was 
compared with that of human embryonic stem cells (hESCs). The highly glycolytic stem 
cells increased their mitochondrial mass and activity as they differentiated towards a 
beta cell like phenotype thereby switching to oxidative phosphorylation as the primary 
energy source. The ratio of glycolytic to mitochondrial respiration (ECAR/OCR) was 
calculated at high (20mM) and low (2mM) glucose. This ratio was shown to be higher in 
hESCs than in SC-βs indicating relatively higher glycolysis in hESCs. The ratio increased 
slightly when the glucose concentration increased which may indicate an increase in 
glycolytic contributions to energy production under stimulating conditions [121]. 
 
In this study, to determine whether the improved GSIS in pseudoislets could be due to 
improved coupling of glycolysis to mitochondrial metabolism, flux through glycolysis and 
mitochondrial respiration was assessed using the seahorse bioanalyser (Agilent). This 
system allows accurate measurement of the oxygen consumption rate oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) in real time by 
lowering a probe containing an oxygen sensor and a pH sensor into each well and taking 
measurements in a transient micro-chamber above each cell sample [100]. Compounds 
can then be injected into the wells and the influence on the metabolism recorded. 
Typically, the first measurements will be taken before any injections; these initial 
measurements record basal metabolism. At seven-minute intervals, the oxygen 
consumption and proton excretion rate were measured for a period of three minutes, 
from this the OCR and ECAR can be calculated. After three measurements of basal 
cellular OCR and ECAR have been recorded, compounds or substrates to activate or 
inhibit respiration were added sequentially through injection ports. The first injection 
was either base media at 0.5mM glucose, 25mM glucose or 10mM pyruvate. The second 
injection contained the ATP synthase inhibitor oligomycin to block oxidative 
phosphorylation so that the mitochondrial respiration associated with ATP production 
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can be calculated from the resulting decrease in OCR. The third injection used in the 
Agilent seahorse protocols is the uncoupling agent FCCP which results in the uninhibited 
electron flow through the electron transport chain so that oxygen is maximally 
consumed by complex IV to establish maximal respiratory capacity. Finally, either 
Antimycin A is injected inhibiting complex III to assess non-mitochondrial respiration or 
2-DG to block glycolysis and measure non-glycolytic acidification. Figure 26 shows 
common cellular responses to the compounds listed in the Agilent protocols and some 
of the mitochondrial and glycolytic parameters that can be calculated from the data.  
 
Glycolytic rate is determined by measurement of extracellular acidification which is 
predominantly determined by lactate release from cells since lactate separates at 
neutral pH to form two lactate ions and two protons, leading to a decrease in pH. 
However, CO2 produced during the mitochondrial metabolism of glucose through the 
TCA cycle also contributes to extracellular acidification. In the TCA cycle, one glucose 
molecule will yield six CO2 molecules resulting in six HCO3- and six protons [125]. From 
this we can see that the ECAR due to mitochondrial metabolism is three times greater 
than that due to glycolysis. The rate of mitochondrial metabolism is already calculated 
from the OCR, so any contributions of mitochondrial metabolism to the ECAR can be 
subtracted allowing the rate of glycolysis to be calculated from the remaining ECAR. The 
pH and buffering potential of the media was also considered in this calculation. This 
method of measuring the contributions of ATP production from glycolysis has been 




The aim was to compare the metabolic flux of 2D vs 3D structures to determine whether the 





• Optimise seahorse bioanalyser protocols to compare metabolism of beta cells 
cultured in 2D or 3D structures 
• Measure ATP production from glycolysis and mitochondrial metabolism in beta 
cells  
• Compare metabolic responses to glucose and pyruvate in the 2D and 3D 
structures. 















Figure 26. Seahorse Bioanalyser Parameters [100] 
  
Examples or metabolic function parameters that can be calculated from Seahorse 
Bioanalyser data taken from the “Agilent Seahorse XF Cell Mito Stress Test Kit User 
Guide” and the “Agilent Seahorse XF Glycolysis Stress Test Kit User Guide”  
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4.2. XFe96 Bioanalyser Optimisation 
 
To begin optimisation for measuring the metabolic function of beta cells in 2D and 3D 
structures, the Agilent Seahorse XF user guides were used. The utilisation of the XFe96 
bioanalyser was explored first as this machine was in the same building as the cells and 
would avoid any unnecessary transport of the samples to other locations. Initially, the 
Agilent user guide was used to determine whether this format would be appropriate for 
accurate measurement of flux in both 2D and 3D structures. The plan was to determine 
the appropriate conditions and concentrations of oligomycin to assess ATP-linked 
mitochondrial respiration and FCCP to assess the maximal respiration capacity. This was 
done first in monolayer culture as it is a more simplistic model. The next step was to use 
these optimised conditions to assess the validity of the method to measure metabolic 
flux in 3D structures. Using a 96 well plate format, the oligomycin and FCCP 
concentrations required to gain maximal functional response in MIN6 cells were 
optimized. All other concentrations used throughout the use of the XFe96 bioanalyser 
were according to those listed in the user guides. The concentrations of compounds 
placed in the cartridge to be injected were 10 times higher than the final concentration 
in the well after injection. To avoid confusion, the concentrations described always refer 
to the final concentration in each well. 
 
4.2.1. Selection of oligomycin and FCCP concentrations for seahorse analyser 
 
ECAR and OCR measurements were recorded at varying concentrations of oligomycin 
and FCCP respectively (figures 27-30). ECAR changes were measured by subtracting the 
third ECAR measurement after glucose addition from the highest measurement after 
oligomycin addition, the resulting values showed an increase between 0.5µM and 2µM 
oligomycin with the greatest response seen at 2µM oligomycin which is the highest 
recommended dose in the seahorse Agilent protocols (Figure 27, Figure 28). OCR 
changes were measured by subtracting the third OCR measurement after oligomycin 
addition from the highest measurement after FCCP addition, this showed an increase 
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between 0.125μM FCCP and 0.5μM FCCP but no further increase was seen at higher 
doses so 0.5µM FCCP was selected to be used in future experiments (figures 29 and 30). 
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Figure 27. ECAR Response to Oligomycin Titrations 
ECAR response in MIN6 (P21 - P25) monolayers after addition of 25mM glucose, either 
0 µM, 0.5 µM, 1µM or 2µM oligomycin, then 50mM 2-DG measured on a seahorse 
XFe96 bioanalyzer. MIN6 were cultured for 24 hours on a 96 well microplate and 
starved for one hour in 0.5mM glucose prior to the experiment. 4 to 5 technical 
repeats per data point, n=1. 
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Figure 28. ECAR Increase After Oligomycin Injections 
ECAR response on MIN6 (P21 – P25) monolayers after addition of oligomycin at 
0.5µM, 1µM, or 2µM measured on a seahorse XFe96 bioanalyzer. MIN6 were 
cultured for 24 hours on a 96 well microplate and starved for one hour in 0.5mM 
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Figure 29. OCR Response to FCCP Titrations 
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Figure 30. OCR Increase after FCCP Injections
 
OCR increase shown by MIN6 (P21 – P25) monolayers under 2µM oligomycin 
after addition of FCCP at 0µM, 0.125µM, 0.25µM, 0.5µM, or 1µM measured on 
the XFe96 seahorse bioanalyzer. MIN6 were cultured for 24 hours on a 96 well 
microplate and starved for one hour in 0.5mM glucose prior to the 
experiment.14-16 technical repeats N=1, * = p<0.005, *** p<0.0001 
OCR response in MIN6 (P21 – P25) monolayers after addition of 2µM oligomycin, 
FCCP at one of six different concentrations, then 0.5µM rotenone and antimycin A 
measured on a seahorse XFe96 bioanalyzer. MIN6 were cultured for 24 hours on a 
96 well microplate and starved for one hour in 0.5mM glucose prior to the 
experiment. 14 to 16 technical repeats per data point, n=1. 
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The OCR of MIN6 monolayers was measured in response to injections of oligomycin, 
FCCP, and a combined injection of antimycin A and rotenone added sequentially and 
recorded over time (figure 31). Injection of oligomycin decreased OCR enabling a clear 
measurement of ATP production from mitochondrial respiration. The FCCP injection 
caused the OCR to return to the basal level recorded in the initial measurements before 
any injections showing that basal respiration is similar to maximal respiration and the 
rotenone and antimycin A were successful in blocking mitochondrial respiration. 
 
The measurement of ECAR to establish glycolytic function involved an initial injection of 
25mM glucose, this concentration was chosen because it is known to stimulate insulin 
secretion in beta cells. The second and third injections contained oligomycin and 2-DG 
respectively (figure 32). After the first injection of 25mM glucose a clear increase in ECAR 
is seen, followed by a decrease in response to the oligomycin injection. There didn’t 
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Figure 31. Monolayer OCR Response in XFe96 Analyser 
OCR response on MIN6 (P21 – P25) monolayers in 10mM glucose after addition of 
2µM oligomycin, 0.5μM FCCP, then 0.5μM rotenone and antimycin A. Measured on 
a seahorse XFe96 bioanalyzer, MIN6 were cultured for 24 hours on a 96 well 
microplate and starved for one hour in 0.5mM glucose prior to the experiment. 
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Once concentrations were optimised for the MIN6 monolayers, the same protocols were 
used for pseudoislets plated onto the 96 well plates. For accurate measurement of 
metabolic flux it is essential that 3D structures are located in the centre of the well to 
allow for alignment with the sensors on the probe. Any movement would cause 
disruption of these measurements. Therefore, pseudoislets were attached to the wells 
of a XFe96 spheroid microplate through 20 minutes of pre-incubation with Cell-Tak at 
room temperature. The pseudoislets were then placed into each well with seahorse 
base media and the plate was centrifuged to help the pseudoislet to attach firmly. After 
the final wash before the seahorse run around one third of the pseudoislets remained 
ECAR response on MIN6 (P21 – P25) monolayers after addition of 25mM glucose, 
2µM oligomycin, and then 50mM 2-DG measured on a seahorse XFe96 bioanalyzer. 
MIN6 were cultured for 24 hours on a 96 well microplate and starved for one hour 
in 0.5mM glucose prior to the experiment. Data shown is representative of 5 
experiments, error bars based on technical replicates. 
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in place attached to the bottom of the well, the metabolic function of these pseudoislets 
was recorded.   
 
The OCR and ECAR was measured in pseudoislets following the same protocol used for 
the monolayer samples. Due to difficulties in securely attaching the pseudoislets to the 
bottom of each well the measurements were much more variable with large error bars 
(figures 33-34). Often the pseudoislets were washed away before the protein content 
could be analysed. In other cases, pseudoislets moved out of alignment with the sensor 
meaning no or minimal function was recorded. The OCR response of pseudoislets 
showed indications of responsiveness to oligomycin and FCCP but again the data is too 
variable to determine any clear changes (figure 33). The final injection containing 
rotenone and antimycin A successfully blocked mitochondrial respiration in all wells. The 
pseudoislets appear to respond to the addition of glucose by showing an increased ECAR 
after an initial delay but the data shown in figure 34 along with other data is too variable 
to determine a clear pattern or to be reliably used in any further analysis.  
 
As with the monolayers, these measurements were repeated in four other experiments 
all showing some very slight indication of responsiveness but with too much variability 











P s e u d o is le t  O C R  R e s p o n s e
in  X F e 9 6  a n a ly s e r













B a s a l O lig o F C C P R o te n o n e
+  A A
 
Figure 33. Pseudoislet OCR Response in XFe96 Analyser 
 
  
OCR response of MIN6 (P21 – P25) pseudoislets after addition of 2µM oligomycin, 
0.5μM FCCP, then 0.5μM rotenone and antimycin A, measured on a seahorse XFe96 
bioanalyzer. MIN6 pseudoislets formed over 5 days then were cultured for 24 hours 
on a 96 well microplate and starved for one hour in 0.5mM glucose prior to the 
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Figure 34. Pseudoislet ECAR Response in XFe96 Analyser 
 
  
ECAR response on MIN6 (P21 – P25) pseudoislets after addition of 20mM glucose, 
2µM oligomycin, and then 50mM 2-DG measured on a seahorse XFe96 bioanalyzer. 
MIN6 pseudoislets formed over 5 days were then cultured for 24 hours on a 96 well 
microplate and starved for one hour in 0.5mM glucose prior to the experiment. 




4.3. Seahorse XFe24 analyser optimisation 
 
Due to the large variation in function and protein measurements for the pseudoislets, 
an alternative method was investigated. In previous literature islet capture plates have 
been used during the metabolic analysis of islets and pseudoislets [127-129]. Using the 
islet capture plate, the islets are placed in a depression at the base of the well and held 
in place by a capture screen eliminating the need to secure the pseudoislets to the base 
of the well. This type of plate is only available in a 24 well format so requires the use of 
the XFe24 analyser.  The 24 well plate allows a larger number of islets to be plated per 
well reducing the problems associated with accurate protein quantification of a single 
islet. The number of islets per well could be increased from 1 islet to up to 500.  
 
Figure 35 shows light microscope images of the pseudoislets as they are placed in the 
well under the islet capture screen.  
 
 
Protocols using the XFe24 analyser were optimized. First the optimal seeding density for 
the monolayer plates was established (Figure 36). There was an increase in recorded 
Light microscope images of MIN6 pseudoislets in a 24 well plate under an islet 
capture screen with the focus on a) the mesh of the islet capture screen and b) the 
pseudoislets underneath the screen. 
A B 
Figure 35. Light Microscope Image of Pseudoislets in Islet Capture Plate 
95 
 
function seen by a higher basal OCR at a seeding density of 80,000 cells/well than 60,000 
cells/well but negligible difference seen between the two highest seeding densities of 
80,000 cells/well and 100,000 cells/well, flux was corrected for protein concentration. 
From this, the seeding density of 80,000 cells/well was selected for future investigations. 
The FCCP concentration was optimised again this time following advice from protocols 
in the laboratory where the XFe96 bioanalyser was used. The first FCCP injection at 3μM 
FCCP was followed with a further FCCP injection of 1μM to establish if there was any 
further increase in maximal respiration. The second injection had little effect so a 
concentration of 3.5μM FCCP was chosen to be sufficient.  
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Figure 36. Monolayer Density and FCCP Optimisation 
 
The optimal protocol for the plating of the islets was then investigated (Figure 37). Islets 
were seeded at either 100 or 300 islets per well and half were plated on the morning of 
OCR response in MIN6 (P26 – P29) monolayers cultured at densities of 60,000 
cells/well, 80,000 cells/well and 100,000 cells/well after addition of 1mM oligomycin, 
3µM FCCP, a further 1µM FCCP then at Antimycin A. Measured on a seahorse XFe24 
bioanalyzer and starved for one hour in 0.5mM glucose prior to the experiment. Six 




the run (day six) with the other half being plated into the islet capture plate the night 
before the run (day five). The highest basal measurements and greatest responsiveness 
to stimulating compounds were seen in pseudoislets plated at the higher density (300 
islets) and plated the night before the run allowing them time to recover after moving. 
However, it was also clear from these results that more adjustments needed to be made 
to the protocol. With the exception of the initial basal measurements, the OCR did not 
reach a plateau meaning the maximal respiration after each injection couldn’t be 
measured. To allow the pseudoislets time to reach a plateau, the time between 
injections was increased. This was not necessary for the monolayers as a clear maximal 
response was seen after each injection. Also, there was no clear response to glucose or 
oligomycin in the pseudoislet measurements and this needed to be understood before 
collecting the final data.  
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Figure 37. Pseudoislet Seahorse Plating Optimisation 
 
Measurements taken on the XFe24 seahorse bionanlyser. OCR measurements of 
MIN6 (P26 – P29) pseudoislets plated at low or high densities either on the morning 
of the seahorse experiment (Day 6) or the night before (Day 5). Initial measurements 
were taken in basal media at 0.5mM glucose then injections of 25mM glucose, 2µM 
oligomycin, then antimycn A were added sequentially. MIN6 pseudoislets were 
cultured for 24 hours on a 24 well microplate and starved for one hour in 0.5mM 
glucose prior to the experiment. Representative of 5 experiments. 
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The OCR measurements of monolayer and pseudoislet cultures were compared (figure 
38). Whilst the monolayers reached a clear plateau after the addition of oligomycin, the 
pseudoislets did not respond to the oligomycin injection. It has been reported that 
higher concentrations of oligomycin are required to penetrate through 3D structures 
[130]. To explore if this was the case with pseudoislets, the oligomycin concentration 
was increased by 10 times in future experiments (figure 39). 
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Figure 38. MIN6 Monolayer and Pseudoislet Response to Oligomycin 
 
Neither culture type, monolayers nor pseudoislets, responded to the glucose injection 
(figures 38). These MIN6 are known to produce a large insulin secretion response under 
the levels of glucose injected as shown in chapter 3 which would rely on a high level of 
metabolism and therefore oxygen consumption. It is possible that the pyruvate in the 
base media is providing the MIN6 with fuel for the insulin secretion, which is masking 
the effect of the added glucose, so it was removed from the media in the next 
OCR response of monolayer and pseudoislet MIN6 (P26 – P29) after addition of 
25mM Glucose then 2µM oligomycin. Measured on a seahorse XFe24 bioanalyzer. 
MIN6 pseudoislets formed over 5 days were then cultured for 24 hours on a 24 well 
islet capture plate. Monolayer samples were cultured for one hour in a 24 well 




experiment. As beta cells are not expected to be responsive to pyruvate [54], the effect 
of a pyruvate injection on the beta cell metabolism will also be investigated. 
 
4.4. Comparison of Metabolic Function for monolayer and pseudoislet MIN6 
 
4.4.1. OCR Measurements  
 
Using the optimal seeding protocols and compound concentrations determined above 
the OCR and ECAR of MIN6 monolayers and pseudoislets were measured in order to 
calculate the ATP contributions from both glycolytic and mitochondrial metabolism. The 
OCR measurements required for these calculations included the OCR under the 
following conditions:  
1. basal glucose 
2. glucose stimulation 
3. pyruvate  
4. oligomycin 
5. antimycin A.  
 
The use of both rotenone and antimycin A was not deemed necessary as antimycin A 
would sufficiently block mitochondrial respiration [131]. For the calculation of the 
glycolytic contribution to ATP production, only the maximal ECAR under stimulation was 
used. The use of 2-DG to block glycolysis was not effective in beta cells due to the low 
expression of low Km of hexokinase [58] and as ECAR was reduced to negligible levels in 
the presence of antimycin A, 2-DG was omitted.  
 
The MIN6 cultured as monolayers showed a similar increase in OCR after addition of 
either glucose or pyruvate (figure 39). There was a decrease in OCR after addition of 
oligomycin indicating successful inhibition of oxidative phosphorylation and a further 
decrease in OCR after addition of antimycin A indicating complete inhibition of the 
electron transfer chain. Rates reached a plateau before each subsequent injection. In 
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contrast, pseudoislets responded robustly to glucose but not to pyruvate (figure 40). As 
with monolayers, a clear response to oligomycin and antimycin A was recorded. 
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Figure 39. OCR of Monolayer MIN6 
 
OCR response in MIN6 (P26 – P29) monolayers after addition of either i) 25mM 
glucose, 0.5mM glucose injection (Basal), or 1mM pyruvate; ii) 2µM oligomycin; iii) 
0.5µM Antimycin A. Measured on a seahorse XFe24 bioanalyzer. Monolayer 
samples were cultured for 24 hours in a 24 well microplate then starved for 1 hour 
in 0.5mM glucose for one hour prior to the experiment. N=3. 
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4.4.2. ECAR Measurements 
 
The ECAR measurements for the monolayer cultures showed a small but consistent 
response to glucose (figure 41). However, these responses were much more evident in 




OCR response in MIN6 (P26 – P29) pseudoislets after addition of either i) 25mM 
glucose, 0.5mM glucose injection (Basal), or 1mM pyruvate; ii) 20µM oligomycin; 
iii) 0.5µM Antimycin A. Measured on a seahorse XFe24 bioanalyzer. MIN6 
pseudoislets formed over 5 days then were cultured for 24 hours on a 24 well 
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Figure 41. ECAR of Monolayer MIN6 
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Figure 42. ECAR of Pseudoislet MIN6 
ECAR response in MIN6 (P26 – P29) monolayers after addition of either i) 25mM 
glucose, 0.5mM glucose injection (No Stimulation), or 1mM pyruvate; ii) 2µM 
oligomycin; iii) 0.5µM Antimycin A. Monolayer samples were cultured for 24 hours 
in a 24 well microplate then starved for 1 hour in 0.5mM glucose for 1 hour prior 
to the experiment. Measured on a seahorse XFe24 bioanalyzer.  N=3 
ECAR response in MIN6 (P26 – P29) pseudoislets after addition of either i) 25mM 
glucose, 0.5mM glucose injection (Basal), or 1mM pyruvate; ii) 20µM oligomycin; 
iii) 0.5µM Antimycin A. Measured on a seahorse XFe24 bioanalyzer. MIN6 
pseudoislets formed over 5 days then were cultured for 24 hours on a 24 well 




4.4.3. Contribution of oxidative phosphorylation and glycolysis to ATP Production in 
MIN6 monolayers and pseudoislets 
 
The mitochondrial oxygen consumption rate correlates to mitochondrial ATP production 
and can be calculated from the total cellular oxygen consumption rate minus the cellular 
consumption rate not associated with mitochondrial activity such as through proton leak 
across the mitochondrial inner membranes (see calculation in methods [131]). Increases 
in ECAR in response to the production of lactate through glycolysis and glycolytic ATP 
production can be calculated from the total cellular ECAR minus the contribution to 
extracellular acidification from carbonic acid generated from CO2 produced during the 
complete oxidation of glucose in mitochondrial metabolism [131]. The ATP production 
per mg protein was calculated using the OCR and ECAR data generated to find the total 
ATP production from oxidative phosphorylation and glycolysis. 
 
The overall ATP production from the monolayers was more variable than that of the 
pseudoislets possibly due to being more sensitive to MIN6 passage number (figure 43). 
There was no significant difference between the basal ATP production between 
monolayers and pseudoislets but there was a trend towards lower basal ATP in 
pseudoislets which is consistent with the trend towards lower basal insulin secretion in 
section 3.7.4. Pseudoislets showed a significantly (P=0.0111) larger insulin secretion 
response to glucose stimulation compared to monolayers (figure 25). There appears to 
be a slightly higher ATP production in monolayers stimulated by pyruvate than in 
pseudoislets although the response measured was quite variable and no statistical 
significance was found. This suggests that monolayers responded to both glucose and 
pyruvate whilst pseudoislets responded only to glucose and not pyruvate.  
 
Monolayers showed a significantly higher basal ATP production from oxidative 
phosphorylation. Neither glucose nor pyruvate increased ATP production from oxidative 
phosphorylation in the monolayers but this may be due to a high variability between 
samples (figure 44). However, pseudoislets showed a clear increase in ATP production 
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Figure 44. ATP Production from Oxidative Phosphorylation in Monolayers and 
Pseudoislets 
Total ATP produced per minute by monolayers and pseudoislets stimulated by either 
glucose or pyruvate. Measured by the seahorse XFe24 bioanalyser. MIN6 (P26 – P29) 
pseudoislets formed over five days were then cultured for 24 hours on a 24 well islet 
capture plate. Monolayer samples were cultured for 24 hours in a 24 well microplate. 
N=3, *=P<0.05, **=P<0.01. Statistical analysis performed but not found to be significant 
when not indicated.  
Total ATP produced per minute by oxidative phosphorylation in MIN6 (P26 – P29) 
cultured as monolayers and pseudoislets and stimulated by either glucose or 
pyruvate compared with glycolytic ATP production of MIN6 monolayers and 
pseudoislets kept in basal media at 0.5mM glucose. Measured by the seahorse 
XFe24 bioanalyser N=3, *=P<0.05 
Figure 43. Total ATP Production in Monolayers and Pseudoislets 
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Basal glycolytic rates were low in both monolayers and pseudoislets (figure 45). 
However, pseudoislets showed a greater (4-fold) increase in glycolysis in response to 
glucose compared to monolayers.  
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Figure 45. ATP Production from Glycolysis in Monolayers and Pseudoislets 
4.5. Analysis of Metabolic Function in Human Islets Stimulated by Glucose or 
Pyruvate 
 
Comparison of the MIN6 pseudoislet function with isolated human islet function will 
help in understanding whether aspects of the metabolic function are a feature of the 
MIN6 model. In previous studies, human islets have been analysed using the seahorse 
bioanalyser [124, 132, 133], where the OCR has been shown to increase on addition of 
glucose [134]. The ECAR is not mentioned in most studies but one paper reported that 
the enhanced insulin secretion in response to addition of fatty acids was due to both 
Total ATP produced per minute by glycolysis in MIN6 (P26 – P29)  
cultured as monolayers and pseudoislets and stimulated by either glucose or pyruvate 
compared with ATP production of MIN6 monolayers and pseudoislets kept in basal 
media at 0.5mM glucose. Measured by the seahorse XFe24 bioanalyser N=3, 




OCR and ECAR increases indicating an increase in both glycolytic and mitochondrial ATP 
contributions [124].  To explore the metabolic function of human islets, OCR and ECAR 
were measured using the same seahorse bioanalyser protocols used to measure 
metabolic function in the MIN6 monolayer and pseudoislets. Human islets were cultured 
for one day post isolation to allow recovery from any stresses before experiments.  
 
The OCR measurements shown in figure 46 appear to show a slight increase in OCR 
following addition of glucose and no response in islets with no stimulation or pyruvate 
stimulation. There are many factors of different natures before, during, and after 
isolation which can affect the function of the human islets. This led to a large variability 
in the function of the islets. 
 
Investigations into the effect of glucose and pyruvate on the ECAR of human islets (figure 
47) showed a similar metabolic function to that seen in the MIN6 pseudoislet samples. 
The ECAR does show a very clear increase after glucose is added suggesting uncoupling 
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Figure 46. OCR of Human Islets 
 
OCR response in human islets after addition of either i) 25mM glucose, 0.5µM 
glucose injection (No Stimulation), or 1mM pyruvate; ii) 20µM oligomycin; iii) 0.5µM 
Antimycin A. Measured on a seahorse XFe24 bioanalyzer. Islets were cultured for 24 
hours on a 24 well microplate and starved for one hour in 0.5mM glucose prior to 
the experiment. N=4. 
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Figure 47. ECAR of Human Islets 
 
 
4.6. Contribution of oxidative phosphorylation and glycolysis to ATP 
Production in Human Islets 
 
The total ATP production in response to glucose was significantly higher (3-fold) for 
human islets stimulated by glucose than for those with no stimulation (figure 48). There 
is no difference between the overall ATP production of islets with no stimulation and in 
the presence of pyruvate. This was similar to the response of the pseudoislets with a 
large glucose triggered ATP production and no response to the pyruvate.  
ECAR response in human islets after addition of either i) 25mM glucose, 0.5µM 
glucose injection (No stimulation), or 1mM pyruvate; ii) 20µM oligomycin iii) 0.5µM 
Antimycin A. Measured on a seahorse XFe24 bioanalyzer. Islets were cultured for 24 
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Figure 48. Total ATP Production in Human Islets 
 
 
The individual contributions of oxidative phosphorylation and glycolysis to ATP 
production in human islets mirrored the pattern seen in the overall contribution. 
Calculations showing ATP production from both oxidative phosphorylation and 
glycolysis showed that there was no response after the addition of pyruvate. 
 
ATP production due to oxidative phosphorylation increased on addition of glucose 
(figure 49). A large portion, around 75%, of ATP production at basal glucose levels was 
contributed to by oxidative phosphorylation. 
Total ATP produced per minute by human islets stimulated by either glucose or 
pyruvate. Measured by the seahorse XFe24 bioanalyser. Islets were plated on a 24 
well islet capture microplate 24 hours before the run and kept in basal media at 
0.5mM glucose. N=3, **=P<0.005 
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A larger contribution to the increased ATP in response to glucose was made by glycolysis 
(figure 50). There was no statistically significant increase in ATP Production between 
islets with no stimulation and glucose stimulation but a large statistically significant 
increase in glycolytic ATP production between these two conditions.  
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Figure 49. ATP Production from Oxidative Phosphorylation in Human Islets 
 
 
Total ATP produced per minute by oxidative phosphorylation in human islets 
stimulated by either glucose or pyruvate. Measured by the seahorse XFe24 
bioanalyser. Islets were plated on a 24 well islet capture microplate 24 hours before 
the run and kept in basal media at 0.5mM glucose. N=3. Statistical analysis 
performed but not found to be significant. 
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4.7.1. Seahorse Bioanalyser Optimisation 
 
Attempts to optimize protocols for bioenergetic measurements using the XFe96 
analyser were successful for monolayer cultures. Measurements recorded using the 96 
well spheroid plates for pseudoislets showed some responsiveness to the compounds 
injected but the variation between wells was too great to obtain accurate data. This was 
mainly caused by difficulties in securing islets in the base of the well causing pseudoislets 
to move out of alignment with the sensors during measurements or to be lost during 
washes meaning protein could not be quantified. Other studies have successfully used 
both coated 96 well spheroid plates [133, 134] to analyse islets and 24 well islet capture 
plates [132, 135]. 
 
Total ATP produced per minute by glycolysis in human islets stimulated by either 
glucose or pyruvate. Measured by the seahorse XFe24 bioanalyser. Islets were 
plated on a 24 well islet capture microplate 24 hours before the run and kept in 
basal media at 0.5mM glucose.  N=3, ***=P<0.001 
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The protocols developed on the XFe96 analyser were further developed on the XFe24 
analyser. This larger well volume allowed more islets to be plated per well and 
incorporated an islet capture screen which held the islets in place throughout 
measurements. After further optimization, the variation in the data generated for the 
pseudoislet OCR and ECAR was reduced so that responses to the compounds injected 
could be measured accurately. Additionally, some changes were made to the media and 
compounds used in the injections in a movement away from the Agilent seahorse 
protocols to focus only on data relevant to this study. Initially, in data produced during 
optimisation of the oligomycin concentration, the OCR was not affected by injection of 
high glucose for either culture types which may be explained by base media containing 
pyruvate. To assess the influence of glucose stimulation on OCR the pyruvate was 
removed from the base media. Previous studies have shown that cells are unable to 
reach their maximum respiration capacity in the presence of FCCP when pyruvate is not 
present in the media and as the use of FCCP was not required in the calculation for the 
ATP production of the MIN6 cells this injection was removed. Finally, 2-DG was judged 
to be ineffective in the inhibition of glycolysis due to the low expression of low Km 
hexokinases in beta cells, so the final injection contained only antimycin A [58].  
 
In early experiments pseudoislets appeared slower to respond to compounds and to 
reach a plateau or seemed to not respond at all. This may be due to the time taken for 
the diffusion of compounds, particularly oligomycin, through the 3D structure of the 
pseudoislets. The number of measurements between each injection was therefore 
increased during pseudoislet experiments and a higher concentration of oligomycin was 
used to fully inhibit ATP linked respiration. This optimisation approach allowed 
development of the technique to allow for accurate comparison of monolayer and 
pseudoislet samples. Although there are limitations due to some differences in the 
experimental setup for 2D and 3D structures, the Seahorse XF bionanalyser has been 
successfully used to compare metabolic characteristics of 2D and 3D structures [130, 
136, 137]. Russell et al also showed that in comparison to 2D structures, 3D structures 
showed delayed effects after addition of oligomycin but not after addition of FCCP, 
rotenone, or antimycin A. Oligomycin has a relatively larger molecular weight which 
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could slow penetration through the 3D structure but it was shown that this feature was 
not solely responsible for the delayed response [130]. Using this system to compare 
monolayer and pseudoislet samples provides useful information but limitations in direct 
comparisons caused by the different cultures requiring different experimental set ups 
should be considered at all stages.  
 
4.7.2.  Total ATP Production in Response to Glucose is Greater in 3D Structures 
 
The total cellular ATP production rate was calculated using the data generated by the 
seahorse bioanalyser. An increase in ATP production under high glucose by pseudoislets 
would indicate improved cell functionality as insulin secretion is tightly linked to ATP 
production [54, 59, 67]. The MIN6 consistently responded to glucose stimulation with 
pseudoislets showing a significantly larger ATP production rate than monolayers under 
high glucose conditions. The improved ATP production response mirrors glucose 
stimulated insulin secretion data in chapter 3. Pseudoislets stimulated by high glucose 
levels showed a 4.8-fold increase in overall ATP production (figure 43) and a 7.4-fold 
increase in insulin secretion levels (figure 25). The MIN6 monolayers were much less 
responsive showing only a 1.6-fold increase in ATP production (figure 43) and a 1.5-fold 
increase in insulin secretion (figure 25). This data shows that changes in metabolic flux 
directly correlate with insulin secretion. 
 
There was no significant effect of glucose on monolayer ATP production, this may be 
complicated by the high levels of variation evident in these data sets, possibly due to 
varying passage numbers. Previous data presented in section 3.5.3 and discussed in 
section 3.8.2 showed that the insulin secretion response of monolayers decreased with 
passage number whilst the MIN6 arranged as pseudoislets retained their function 
regardless of passage number. It may also be due to differences in functionality of the 
MIN6 between batches [138]. The more consistent levels of response displayed by the 
pseudoislets may be due to improved connections and therefore communications 
between beta cells resulting in a more co-ordinated response. Previous studies have 
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shown that cell-cell communication between beta cells is necessary for efficient GSIS, 
the secretion response of dispersed islets was reported to be lower than that of intact 
islets and return to near previous levels when the beta cells were allowed to re-
aggregate [72]. The data in this study suggests that the effect of pseudoislet formation 
on GSIS is perhaps not only due to Ca2+ synchronisation as previously suggested [98] but 
supports a role for a change in metabolic phenotype. We hypothesised that pseudoislets 
would show improved coupling of glycolysis to mitochondrial metabolism. We did see 
an increase in glucose-induced oxidative phosphorylation in pseudoislets compared to 
monolayers, but the largest effect was in uncoupled ATP production which is not 
consistent with the original hypothesis. Very few studies have investigated the 
relationship between glycolysis and GSIS. However, Chowdhury et al reported higher 
protein expression levels of both glycolytic and mitochondrial enzymes in pseudoislets 
compared to monolayers [78] and a significant increase in glycolysis in response to fatty 
acid stimulation has been reported in human islets [124].  
 
4.7.3. Increased Basal ATP Production in 2D Beta Cells is caused by an Increase in 
Oxidative Phosphorylation 
 
The ATP contributions from both oxidative phosphorylation and glycolysis were then 
examined separately. The most obvious difference within the production of ATP from 
oxidative phosphorylation was the increased level of basal ATP production in the 
monolayer samples. The lack of significant effect of glucose on total ATP production in 
monolayers may be explained by the higher level of basal ATP production. The overall 
ATP production and the insulin secretion data both showed slightly raised basal levels in 
monolayer samples, but this is much more pronounced in OCR data suggesting it is a 
feature of increased oxidative phosphorylation. High ATP production in beta cells at low 
glucose levels can trigger inappropriate insulin release and is indicative of a less efficient 
pathway [14, 87, 112, 139].  
 
It has also been shown that inhibition of Cx36 in beta cells results in a higher basal insulin 
secretion [140]. This is because hyperpolarising Ca2+ waves can spontaneously occur in 
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beta cells, these waves can be dispersed throughout the islet when there is 
communication between beta cells but isolated beta cells are not able to do this and so 
prone to increased basal insulin secretion rates [73, 74, 98, 140]. Dispersed beta cells 
such as those cultured as monolayers have much fewer intercellular connections such 
as Cx36 than beta cells within islets and pseudoislets and so the lack of this gap junction 
serves as another potential cause of the increased basal ATP production [94, 103]. This 
is a more likely cause for the increased basal OCR in monolayers and investigation into 
the effect of Cx36 expression on basal OCR would be of interest in understanding the 
mechanisms behind this. 
 
All samples showed an increase in OCR with high glucose which correlates to increased 
ATP production from oxidative phosphorylation. There was no difference in ATP 
production under high glucose between monolayer and pseudoislet samples suggesting 
ATP was being produced through a different pathway, so this was further explored in 
the next section through the analysis of glycolytic ATP contributions.  
 
4.7.4. Pancreatic Beta Cells Display Improved ATP Production Responsiveness When 
Cultured as 3D Structures due to Increased Glycolysis 
 
The increased ATP production seen in the pseudoislets was mainly due to the increased 
glycolytic contribution and human islets used in this study also displayed a similar 
increase in glycolysis in response to high glucose. Both human islets and MIN6 
pseudoislets produced more than half of the overall ATP under high glucose from 
glycolytic contributions. Existing literature investigating pseudoislet metabolism using 
the seahorse bioanalyser focuses only on the OCR portion of metabolism. Some articles 
that do include ECAR data consistently show an increase in ECAR in response to glucose 
stimulation [141-143]. However, none of this data is analysed further or discussed and 




A large glycolytic response could be a sign of hypoxia. Isolation of islets requires 
disrupting the vascular network supplying the islets with oxygen and leaves diffusion as 
the only option to supply the nutrients and oxygen required by the islets. This means 
that all islets suffer some effects of hypoxia following isolation, particularly in the core 
of the islet. The effects of hypoxia are present to some degree until transplantation and 
revascularisation is complete [144]. The increase in glycolysis seen in the islets and 
pseudoislets may indicate a limitation in the study of islets outside their natural 
environment.  
 
To maintain blood glucose at sufficient levels to meet the body’s demands it is important 
that insulin is not released at low glucose levels. GLUT2 is a major glucose transporter in 
rodent beta cells that allows rapid equilibrium between intracellular and extracellular 
glucose concentrations [145]. This transporter is vital in enabling the cells to respond 
almost immediately to any changes in glucose concentration. Once glucose has been 
transported into the beta cell, glucokinase acts as a glucose sensor; metabolising glucose 
only once it exceeds physiological levels [58]. It is important that the low km hexokinase-
1 is not expressed in beta cells. High expression of hexokinase-1 would lead to 
inappropriate insulin secretion during fasting [53]. There is evidence that hypoxia 
decreases basal OCR but it also decreases maximal respiratory capacity [146]. The 
maximal capacity wasn’t recorded in this study as the use of FCCP was deemed 
unsuitable, however, the pseudoislets indicated an increase in glucose mediated OCR 
suggesting the data is not consistent with a loss of aerobic respiration that would be 
expected in hypoxia. Hypoxia increases basal insulin secretion through increased basal 
glycolysis so investigation into the expression of GLUT2 and hexokinase in the 
pseudoislets compared to monolayers could help clarify any changes in the glucose 






4.7.5. Beta Cells in 2D Structures Show Some Response to Pyruvate Stimulation 
 
The metabolic response of MIN6 and human islets to pyruvate stimulation was also 
measured. To achieve good blood glucose control it is important that beta-cells do not 
respond to extracellular pyruvate [54]. The levels of pyruvate and lactate in the blood 
increase following exercise. If these molecules were to be transported into the beta cells 
to be metabolised, they would stimulate insulin secretion causing a potentially 
dangerous drop in blood glucose levels. To prevent this inappropriate insulin secretion 
response the expression of monocarboxylate transporter 1 (MCT 1) is repressed in beta 
cells so that the lactate and pyruvate cannot enter the cell [53].  
 
The MIN6 pseudoislets and human islets in this study did not respond to pyruvate 
stimulation. ATP production in the presence of pyruvate was similar to the ATP 
production with no stimulation. However, the monolayers showed an increase in ATP 
production through oxidative phosphorylation in response to pyruvate stimulation.  This 
suggests that configuration of beta cells as monolayers changes the metabolic 
properties of the beta cell to allow them to respond to pyruvate which is not 
physiological. Further analysis is required to further explore this mechanism. Insulin 
secretion in response to pyruvate has also been seen in cases of exercise induced 
hyperinsulinemic hypoglycaemia (EIHI), which is characterised by inappropriate insulin 
secretion following anaerobic exercise [147]. It has been shown that this form of 
hyperinsulininemic hypoglycaemia is caused at least in part by overexpression of the 
MCT1 transporter. Investigating the expression of this transporter in the MIN6 could 




CHAPTER 5. COMPARISON OF BETA CELL METABOLIC ACTIVITY IN 




Data in previous chapters showed that MIN6 cells cultured as pseudoislets display an 
improved glucose stimulated insulin secretion response compared to monolayer MIN6. 
This insulin secretion data mirrors metabolic data which was then produced using the 
seahorse bionanalyser showing that there is a strong link between ATP production and 
insulin secretion. The data from the seahorse bioanalyser provided some insight into the 
effects of cell culture technique on the metabolic function of beta cells under stimulating 
and non-stimulating conditions. This chapter aims to further investigate how metabolic 
pathways are influenced by the improved connectivity seen in beta cells cultured as 3D 
structures and will seek to explain the mechanisms behind the changes in function 
described in the previous chapters. MIN6 pseudoislets showed a similar metabolic 
phenotype to human islets. This includes a low basal ATP production, high ATP 
production in high glucose conditions, and a large proportion (over 50%) of the high ATP 
production being due to an increase in glycolysis. MIN6 monolayers also showed an 
insulin secretion response to extracellular pyruvate. Insulin secretion in response to 
pyruvate can lead to inappropriate insulin secretion causing hypoglycaemia so this 
indicates another potential area of beta cell dysfunction found in 2D culture.  
 
Optimal insulin secretion is thought to rely on tight coupling between glycolytic and 
mitochondrial metabolism so a beta cell functioning in optimal conditions would be 
expected to produce most of its ATP through oxidative phosphorylation [57, 148]. The 
high glycolytic contribution suggests aerobic respiration is being prevented from 
performing at full capacity and so the beta cells are relying on glycolysis to meet the 
energy demands of the cell [149]. It is possible that this is due to hypoxia. Hypoxia can 
be defined as either an oxygen level at which mitochondrial metabolism is compromised 
or as an oxygen concentration lower than that normally experienced by the cell [144, 
149-152]. Hypoxia is known to be a common issue in the core of the pseudoislets and 
118 
 
human islets due to the distance required for the oxygen to diffuse to reach the inner 
cells, because of this, larger islets are inherently more prone to the effects of hypoxia 
[13, 85, 105]. Beta cells have a carefully regulated molecular response to hypoxic 
conditions which begins with the hypoxic inducible factor (HIF) complex which is known 
to influence the expression of at least 70 genes [149]. The genes of interest in this 
chapter are those that allow the cell to adapt to anaerobic metabolism. Metabolic 
markers known to be upregulated in response to hypoxia include GLUT1, PFK, Aldolase, 
GAPDH, and PGK1 along with the down regulation of glucokinase and GLUT2 [145, 153]. 
MCT4 is also upregulated as it is required to transport lactate produced from the 
pyruvate out of the cell [154]. Studies have shown that HIF expression in beta cells leads 
to increased glycolysis, higher basal insulin secretion and impaired glucose tolerance 
demonstrated by a reduced GSIS response [144, 151, 152].  
 
The metabolic profile of pseudoislets showed some properties consistent with a hypoxic 
response but also other features that are not. One feature consistent with hypoxia was 
a high glycolytic component of ATP production in response to glucose stimulation. 
However, the overall increase in ATP production and insulin secretion in pseudoislets 
compared to monolayers suggests the high glycolytic contribution recorded was not a 
result of hypoxia. Previous studies report a blunted GSIS response when hypoxia was 
present [144, 149, 151, 152, 154]. Features of the pseudoislet and human islet metabolic 
phenotype inconsistent with hypoxia included a lower basal insulin secretion and basal 
rate of oxidative phosphorylation and a high glucose stimulated rate of oxidative 
phosphorylation.  Although the oxidative phosphorylative contributions to overall ATP 
production weren’t as high as the glycolytic contributions, 3D structures displayed an 
increased glucose stimulated OCR compared to monolayers. This suggests that the 3D 
arrangement of beta cells allowed for some enhancement of the pathways in 
mitochondrial metabolism.  
 
As described previously, efficient glucose sensing should prevent insulin secretion at low 
glucose as this can lead to hyperinsulinemic hypoglycaemia. It would be expected that 
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inappropriate glucose sensing would result in an increase in glycolysis, which was not 
seen. To investigate the mechanisms causing the increased basal insulin secretion in 
monolayers, the expression of GLUT2 and hexokinase 1 were investigated as these 
proteins act together in sensing and responding to extracellular glucose levels. It is clear 
that there are complex mechanisms involved in the metabolic and functional changes 
between the 2D and 3D structures and these may be elucidated by further exploring the 










• Determine the impact of pseudoislet formation on the expression and activity of 
enzymes involved in glycolysis and the TCA cycle 
• Assess whether pseudoislet formation alters the basal flux of glucose in the beta 
cell. 





5.3. Comparison of Glycolytic Enzyme Activities in 3D vs 2D Structures 
 
An increase in glycolytic enzyme activity may indicate an increase in glycolysis. The 
activity of the glycolytic enzymes, phosphoglucose isomerase (PGI), 
phosphofructokinase 1 (PFK1), Aldolase, GAPDH, and pyruvate kinase (PK) were 
measured for both monolayer and pseudoislet cultures to determine whether formation 
of pseudoislets influenced glycolytic activity (figures 51-55). PFK1 activity was 
significantly higher in pseudoislets compared to monolayers (figure 52). GAPDH activity 
was measured in high passage MIN6 and found to be consistently higher in pseudoislets 
than monolayers P= 0.00014 based on n=4 (figure 54). The culture system had no effect 
on the remaining three enzymes (figures 51, 53, and 55). 

















Figure 51. Phosphoglucose Isomerase Activity in Monolayers and Pseudoislets 
  Mean ± SEM of phosphoglucose isomerase (PGI) activity in cell homogenate of low 
passage MIN6 cells cultured as monolayers vs pseudoislets. N=8. Statistical analysis 
performed but not found to be significant when not indicated. 
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Figure 52. Phosphofructokinase 1 Activity in Monolayers and Pseudoislets 
 
 


















Figure 53. Aldolase Activity in Monolayer and Pseudoislets 
 
 


















Figure 54. GAPDH Activity in Monolayers and Pseudoislets 
Mean ± SEM of GAPDH activity in total cell homogenate of high passage MIN6 cells 
cultured as monolayers (ML) vs pseudoislets (PI). N=4, P<0.0001 
* 
* 
Mean ± SEM of phosphofructokinase 1 (PFK1) activity in cell homogenate of low 
passage MIN6 cells cultured as monolayers (ML) vs pseudoislets (PI). N=8, P<0.05 
Mean ± SEM of aldolase activity in cell homogenate of low passage MIN6 cells 
cultured as monolayers (ML) vs pseudoislets (PI). N=8. Statistical analysis 
performed but not found to be significant when not indicated. 
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It is necessary for LDH activity to be low in beta cells in order to maintain the tight 
coupling between glycolytic and mitochondrial metabolism [69]. LDH activity was 
measured in the same culture systems as the previous glycolytic enzymes (figure 56). 
The activity was consistently higher in the MIN6 cultured as pseudoislets however this 
difference was too small to be statistically significant with a P value of 0.0613.  
















Figure 56. Lactate Dehydrogenase Activity in Monolayers and Pseudoislets 
 
Mean ± SEM of lactate dehydrogenase (LDH) activity in total cell homogenate of 
high passage MIN6 cells cultured as monolayers (ML) vs pseudoislets (PI). N=8. 
Statistical analysis performed but not found to be significant when not indicated. 
Mean ± SEM of pyruvate kinase (PK) activity in cell homogenate of low passage 
MIN6 cells cultured as monolayers (ML) vs pseudoislets (PI). N=8. Statistical 
analysis performed but not found to be significant when not indicated. 
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The higher enzyme activity of several glycolytic enzymes is consistent with the increased 
glycolytic flux measured using the seahorse XFe24 bioanalyser in section 4.4. 
  
5.4. Comparison of Mitochondrial Enzyme Activities in 2D vs 3D Structures 
 
Mitochondrial enzyme activity of TCA cycle enzymes was investigated in monolayer and 
pseudoislet cultures. An increase in mitochondrial enzyme activity could indicate 
increased mitochondrial metabolism which would contribute to enhanced insulin 
secretion. The activities of a few key enzymes for which methods could be optimised 
were measured. The activities of pyruvate carboxylase, citrate synthase, α-ketoglutarate 
dehydrogenase, and malate dehydrogenase (MDH) were higher in pseudoislets than in 
monolayers as shown in figures 57, 58, 60, and 61 respectively.  
 
ICD is an enzyme involved in the TCA cycle that is carefully regulated to avoid over 
accumulation of α-ketoglutarate. This was the only mitochondrial enzyme that was not 
consistently higher in all pseudoislet sample fractions.  
 






















Mean ± SEM of Pyruvate carboxylase activity in cell homogenate of high passage 




















Figure 58. Citrate Synthase Activity in Monolayers and Pseudoislets 
 
 

















Figure 59. Isocitrate Dehydrogenase Activity in Monolayers and Pseudoislets 
















Figure 60. α-Ketogluterate Dehydrogenase Activity in Monolayers and Pseudoislets 
Mean ± SEM of isocitrate dehydrogenase (ICD) activity in low passage MIN6 
cultured as monolayers vs pseudoislets for five days. N=4. Statistical analysis 
performed but not found to be significant when not indicated.   
 
Mean ± SEM of α-ketoglutarate dehydrogenase activity in low passage MIN6 cultured as 
monolayers vs pseudoislets for five days. N=4 P<0.03  
 
Mean ± SEM of Citrate Synthase activity in cell homogenate of high passage MIN6 



























The higher activity of the enzymes from the TCA cycle investigated is consistent with the 
increased rates of oxidative phosphorylation measured using the seahorse XFe24 
bioanalyser in section 4.4.  
 
5.5. Assessment of Hypoxia in Monolayer Vs Pseudoislets 
 
The pseudoislets and human islets used in this study showed a high glycolytic 
contribution to ATP which may be explained by hypoxia. In hypoxic conditions HIFs 
promote a change from aerobic to anaerobic respiration. This involves increasing the 
activity of some glycolytic enzymes along with GLUT1, PDK1, and LDH. The overall effect 
of this is a decrease in mitochondrial oxygen consumption and an increase in glycolytic 
ATP production.  
 
The expression of these genes, GLUT1, PDK1, and LDH, in pseudoislet and monolayer 
MIN6 was quantified using PCR. The results in figure 62 show that the expression of 
hypoxic genes does seem to be higher in pseudoislets but that it is also very variable. 
This is probably due to the variability in sizes of the pseudoislets and the fact that beta 
Mean ± SEM of MDH activity in cell homogenate of high passage MIN6 cells 




cells in the centre of the pseudoislets were much more susceptible to hypoxia than the 
outer beta cells.  
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Figure 62. PCR Analysis of Hypoxic Markers in Monolayers and Pseudoislets 
 
5.6. Investigation into increased Basal ATP Production in 2D structures 
 
The next aim of this chapter is to understand the underlying mechanisms for the 
increase in basal ATP production and insulin secretion that has been shown in monolayer 
MIN6. GLUT2 and glucokinase work together in a glucose sensing mechanism that allows 
the cell to respond almost immediately to changes in extracellular glucose 
concentrations. A decrease in GLUT2 expression is associated with diabetes onset in 
rodents and a reduced ability for the beta cells to respond to changes in glucose 
concentration [153, 155] . GLUT2 is also positively related to the state of differentiation 
of beta cells [156].  
 
Mean ± SEM mRNA expression of genes indicative of hypoxia, Glut1, PDK1, and 
LDH. Expression was measured in monolayer (ML) and pseudoislet (PI) MIN6 (P26 
– P29) after five days of culture. N=4,3,3 respectively. Statistical analysis performed 
but not found to be significant when not indicated. 
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Western blotting (figure 63) showed that GLUT2 expression was significantly higher, 
P=0.0343, in pseudoislet MIN6 than in monolayer MIN6 suggesting that the monolayer 
cultures have a reduced capability in responding quickly to changes in glucose 
concentration.  
 
Figure 63. Western Blot Analysis of GLUT2 Expression  
 
The second part of the glucose sensing mechanism requires low expression of low Km HK 
and high expression of glucokinase [78]. First, the activities of these enzymes were 
measured in monolayer and pseudoislet cultures to determine whether pseudoislet 
formation altered expression. There was a slight increase in low Km hexokinase activity 
in the monolayer cultures that was approaching significance with a P value of 0.0595 
(figure 64).  No differences were found between activities glucokinase in the two 
different culture systems (figure 65).  

































Western blot showing GLUT2 expression in MIN6 monolayers and pseudoislets 
after 5 days of culture. Beta actin was the housekeeping protein used to normalise. 
20μg protein loaded, MIN6 P26-P28. Graph shows mean ± SEM of normalised 




















Figure 64. Hexokinase Expression in Monolayers and Pseudoislets 
 
















Figure 65. Glucokinase Expression in Monolayers and Pseudoislets 
 
The expression of hexokinase I was then also measured using western blotting, the 
expression of hexokinase II and hexokinase III were not investigated due to lack of 
specific antibodies in house. This also showed a higher expression of hexokinase I in 
monolayers than in pseudoislets (figure 66). The increased hexokinase expression and 
decreased GLUT2 expression in the monolayer MIN6 both suggest a decreased glucose 
sensing capacity when the beta cells aren’t cultured in 3D pseudoislet structures 
consistent with the trend towards higher basal insulin secretion in the 2D structures. 
Mean ± SEM of hexokinase activity in the supernatant of low passage MIN6 cells 
cultured as monolayers vs pseudoislets. N=6. Statistical analysis performed but not 
found to be significant when not indicated. 
Mean ± SEM of glucokinase activity in the supernatant of low passage MIN6 cells 
cultured as monolayers vs pseudoislets. N=6. Statistical analysis performed but not 




Figure 66. Western Blot Analysis of Hexokinase I Expression in Monolayers and 
Pseudoislets 
 
5.7. UK5099 Inhibition 
 
Pyruvate produced through glycolysis is shuttled into the mitochondria via 
mitochondrial pyruvate carriers (MPCs) where it is either used as a substrate in oxidative 
phosphorylation, or to replenish intermediates in the TCA cycle [54, 56, 58, 65]. MPC 
plays a role in the beta cell insulin secretion response to glucose and amino acids [157]. 
It has been shown that the addition of the MPC inhibitor, α-cyano-β-(1-phenylindol-3-
yl)-acrylate (UK5099), impairs respiration under both basal and high glucose conditions 
meaning that continuous transport of pyruvate into the mitochondria is required to 
maintain respiratory rates [158]. 
 
UK5099 was used to inhibit transport of endogenous pyruvate through the MPC 
transporters in monolayer and pseudoislet MIN6 and the change in OCR was measured 
using the seahorse bioanalyser. The MIN6 media contained basal levels of glucose and 
L-glutamine and 1mM pyruvate. Figures 67 and 68 show OCR data for monolayers and 
pseudoislets respectively from one experiment and is representative of three 































Western blot showing Hexokinase expression in MIN6 monolayers and 
pseudoislets after 5 days of culture. Beta actin was the housekeeping protein used 





experiments. Calculations from this data found that pseudoislets showed a significantly 
higher percentage reduction in OCR than monolayers (figure 69). This suggests that 
more pyruvate is being shuttled into the mitochondria under basal conditions meaning 
that the oxidative phosphorylation pathway is more active in pseudoislets than 
monolayers in basal conditions.  
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Figure 67. Monolayer OCR Reduction with UK5099 
 
 
OCR response in MIN6 (P26 – P29) monolayers in media containing 0.5mM glucose 
and 1mM pyruvate after addition of 100μM UK5099 then 2µM oligomycin. 
Measured on a seahorse XFe24 bioanalyzer. Monolayer samples were cultured for 
24 hours in a 24 well microplate then starved for 1 hour in 0.5mM glucose for 1 
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Figure 68. Pseudoislet OCR Reduction with UK5099 
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Figure 69.OCR Reduction with UK5099 
 
Mean ± SEM of the percentage reduction in OCR of monolayer and pseudoislet 
MIN6 (P26 – P29) after addition of 100μM  of the MPC inhibitor, UK5099. Data was 
recorded using a Seahorse Bioanalyser XFe24  N=3, P<0.05 
* 
OCR response in MIN6 (P26 – P29) pseudoislets in media containing 0.5mM glucose 
and 1mM pyruvate after addition of 100μM of the MPC transporter UK5099 then 
2µM oligomycin. Measured on a seahorse XFe24 bioanalyzer. Monolayer samples 
were cultured for 24 hours in a 24 well microplate then starved for 1 hour in 0.5mM 
glucose for 1 hour prior to the experiment. N= 4 technical repeats, data 
representative of three experiments. 
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5.8. MCT1 Inhibition 
 
Antibodies were optimised for the detection of MCT1 expression through western 
blotting. Figure 70 shows detection of MCT1 in mouse brain and heart tissue. However, 




 MCT1          54kDa 
GAPDH 35.8kDa 




Western blot analysis of monocarboxylate transporter 1 (MCT1) in murine 
brain and heart tissue. Protein loaded at 20μg, 10μg, and 5μg for both brain 





Understanding how metabolic pathways are influenced by differences in intercellular 
connections between beta cells in 2D and 3D architectures could help in understanding 
why beta cell function is lost during the isolation process. Using this knowledge to 
improve isolation techniques could lead to improved outcomes in islet transplant 
therapies.  
 
5.9.1. Increased Glycolytic Contribution in Pseudoislets 
 
i. Glycolytic Enzyme Activity 
 
Seahorse data showed higher glycolytic ATP production in pseudoislet and human islets 
compared to monolayer MIN6. An increase in glycolytic enzyme activity may indicate an 
increase in glycolysis so the activities of PGI, PFK1, aldolase, glucokinase, GAPDH, and 
PK were compared in the monolayer and pseudoislet samples. The enzymes that were 
significantly influenced by culture system were PFK1 and GAPDH. These were increased 
in the pseudoislet samples when compared to monolayers. PFK1 is associated with the 
regulation of the glycolytic pathway and the generation of insulin oscillations that are 
present in pseudoislets but not monolayers [79].  
 
LDH activity can interfere with glucose sensing as anaerobic metabolism of pyruvate 
produces less ATP than would be produced through mitochondrial metabolism [54]. It 
would therefore be expected that pseudoislets which are reported to have a high insulin 
secretion response would express lower levels of LDH than monolayers which are 
reported to be less responsive to glucose. However, the results in figure 56 show that 
there was a slight trend towards higher LDH activity in pseudoislets than in monolayers. 
Although this trend is inconsistent with the insulin secretion responses reported it does 
support the findings in Chowdhury et al where a 1.4 fold increase in LDH expression was 
reported in pseudoislets when compared to monolayers [80]. It also supports the 
seahorse data which showed that although the pseudoislets were producing more ATP 
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and therefore secreting more insulin than monolayers, a large percentage of this ATP 
was produced through uncoupled glycolysis. 
 
To investigate whether the increase in uncoupled glycolysis was due to the presence of 
hypoxia within the pseudoislet structures, the expression of some key markers of 
hypoxia were measured in pseudoislets and monolayers using RT-PCR. The genes 
included LDH, GLUT1, and PDK1. PDK1 and LDH displayed a trend towards increased 
expression in pseudoislets but with high variability. Hypoxia is known to be a common 
issue in islets as oxygen cannot freely diffuse to the centre of larger islets and this can 
lead to a reduction in function and necrosis [144, 149, 151, 152, 154]. The high variability 
in hypoxic gene markers suggests that at least some beta cells within the islets are 
displaying signs of hypoxia but the effect this will have on the overall function of the islet 
is not certain. However, the decrease in basal ATP production and basal insulin secretion 
is not consistent with a classical hypoxic response. In hypoxia there is an upregulation 
of hexokinase II which increases flux at low glucose concentrations [150]. Pseudoislets 
would be expected to respond to hypoxia through an increase in basal ATP production 
and insulin secretion but in this case the converse is true. Hypoxia may be driving the 
increase in uncoupled glycolysis, but it cannot explain the pseudoislet decrease in basal 
insulin secretion nor the increased glucose responsiveness.  
 
ii. Mitochondrial Enzyme Activity 
 
The activities of the mitochondrial enzymes, PC, citrate synthase, ICD, α-Ketoglutarate 
dehydrogenase, and MDH were recorded in monolayers and pseudoislets. Pseudoislets 
showed an increase in the activities of all these enzymes with the exception of ICD. 
These results suggest an increase in TCA cycle activity in MIN6 cultured as pseudoislets 
compared to in those cultured as monolayers. The reason for this increase in activity is 
unclear. An increase in mitochondrial activity could offer a greater capacity for coupling 
and improved flux through the TCA cycle, this is consistent with increased OCR in 
pseudoislets compared to monolayers and is consistent with data from Chowdhury et al 
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[80]. It could also be a result of increased mitochondrial biogenesis which can be 
investigated through mitochondrial staining or PCR analysis of mitochondrial mRNA.  
 
5.9.2. Increased Basal Insulin Secretion 
 
Monolayer MIN6 showed an increased level of basal insulin secretion compared to 
pseudoislets and human islets. Glucokinase has a low affinity for glucose and so plays an 
important role in maintaining the low basal rate of insulin secretion. Overexpression of 
low Km hexokinase which has a high affinity for glucose is associated with an increase in 
insulin secretion response at low glucose levels [57]. The results of this study show that 
there was no change in Glucokinase activity but that there was a trend towards 
increased hexokinase activity in MIN6 cultured as monolayers and a significant increase 
in hexokinase I expression when compared to those cultured as pseudoislets. High 
GLUT2 expression is required for rapid glucose sensing as extracellular levels fluctuate 
[145, 153]. A higher GLUT2 expression was found in pseudoislets than in monolayers. 
This suggests that pseudoislets are more efficient in sensing changes in extracellular 
glucose concentration. Monolayers showed no change in basal ATP production from 
glycolysis, but a higher basal oxidative phosphorylation rate (figures 44 and 45). This 
increased basal insulin secretion is a feature seen in T2DM. Proposed mechanisms for 
this increase include hypertrophy of the beta cells, an increase in intercellular glycogen 
stores, and an increase in a constitutive secretory pathway working independent of 
metabolic signals [139].  
 
5.9.3. MPC inhibition 
 
Transport of exogenous pyruvate into the beta cell is restricted through a lack of the 
plasma membrane transporter MCT1 [147]. On the other hand, transport into the 
mitochondria of endogenous transport produced through glycolysis within the beta cell 
is necessary for optimal ATP production and therefore insulin secretion [58]. In this study 
endogenous pyruvate transport into the mitochondria was blocked through the MPC 
inhibitor UK5099. This resulted in a greater percentage reduction in the OCR of 
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pseudoislets than monolayers. Possibly because the high insulin secretion response seen 
in pseudoislets is reliant on the shuttling of pyruvate into the mitochondria to produce 
maximal ATP through oxidative phosphorylation. When Islets are cultured under 
starvation conditions, leucine promotes anaplerotic flux of glutamine through 
glutaminase and GDH [159]. As the glucose concentration of the media was low (0.5mM) 
it is possible that L-glutamate was a key fuel source. Future experiments involving 









3D structures showed an improved functional response to 2D cultures as described in 
chapters 3-5. This improved function is also well documented in other studies [80, 85, 
86, 97, 101, 104, 105]. Further analysis into the pathways involved in the metabolic 
function of beta cells in 2D and 3D structures showed two key features. One is that 3D 
structures display a superior glucose sensing function at both basal and high glucose 
levels when compared to 2D culture. The second is that there are still some limitations 
in the pseudoislet and human islet models most likely caused by the difficulties 
associated with maintaining the high oxygen demand to all parts of the islet. 
Nonetheless pseudoislets functioned in a very similar manner to human islets and 
remain the most accessible and relevant model in studying pathways associated with 
diabetes.  
 
Changes in blood glucose concentrations result in oscillations in Ca2+ concentrations 
within the beta cell which trigger insulin secretion [73, 160]. Dispersed beta cells display 
a high variability in Ca2+ responses to glucose stimulation. Once beta cells have formed 
3D structures cytoplasmic Ca2+ concentrations become synchronised leading to 
synchronised insulin secretion oscillations. It is currently believed that the increased 
GSIS response seen in 3D structures in comparison to dispersed beta cells is due to 
synchronisation of calcium signals [98, 140]. This synchronisation results in a greater 
insulin secretion response under stimulation and a more predictable threshold for 
insulin secretion stimulation [107]. The integrated insulin secretion response of the islet 
is greater than the sum of the individual responses of the beta cell within the islet [98]. 
It has been shown that direct contact between the cells is necessary for the 
improvements in the secretory response to be seen so this is not thought to be an effect 




The formation of the 3D structures has been shown to rely on and result in the formation 
of intercellular connections discussed in section 1.5. These connections include cells 
adhesion molecules, gap junctions and communication via paracrine signalling. E-
cadherins are a common cell adhesion molecule that have been shown to play an 
important role in maintaining the structural integrity of the islet and to act as 
mechanoreceptors. Although required for the formation of the islets or pseudoislets, e-
cadherins have not been found to influence the synchronised responses of beta cells [9, 
107]. Paracrine signalling from both beta cells and non-beta cells has not been shown to 
play an important role in regulating the insulin secretion response. Gap junctions 
provide metabolic and electrical coupling between beta cells and have been directly 
correlated with insulin content in the beta cells [9]. It is thought that these gap junctional 
couplings are also responsible for the synchronised insulin secretion response seen in 
3D structures.  
 
One gap junction which has been shown to be important in the co-ordination of beta 
cell responses within islets is Connexin 36 (Cx36) also known as gap junction delta 2 
protein (GJD2). Six protein subunits of Cx36 together form a pore in the beta cell which 
will form a channel when aligned with Cx36 subunits of a neighbouring cell. Molecules 
are then able to pass freely between the beta cells. Cx36 expression has been associated 
with expression of the insulin gene [161]. Pharmacological modulation of connexins has 
so far been non-specific, there are no current pharmacological agents that act 
exclusively on Cx36 and compounds that are used for Cx36 inhibition such as mefloquine 
and heptanol have a limited half-lives so this method of investigation has not reported 
any successful investigations into the effects of Cx36 on beta cell function [95]. 
Knockdown of Cx36 in mice has shown that deleting the Cx36 gene resulted in a lack of 
Cx36 gap junctions forming and this had various effects on the islets. Lucifer yellow is a 
fluorescent tracer compound used to visualise intracellular communication. The lack of 
Cx36 channels prevented the exchange of the lucifer yellow between cells suggesting 
that the gap junction is required to functionally couple the cells. Secondly, the 
knockdown in Cx36 islets resulted in a lack of Ca2+ synchronicity and therefore loss of 
pulsatile insulin secretion which was accompanied by a significant increase in basal 
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insulin secretion [140]. Another study investigating partial and complete knockdown of 
Cx36 reported that islets with partial Cx36 knockdown showed no changes in basal 
insulin secretion but a decrease in the stimulated insulin secretion response. Total 
knockdown of Cx36 in this study resulted in a raised basal insulin secretion as well as the 
lack of insulin secretion response to glucose [94]. The expression of Cx36 has also been 




This chapter aims to investigate the involvement of Cx36 in regulating beta cell 
metabolic function and consequent insulin secretion response.  
Objectives: 
• To develop a mouse beta cell model with inducible Cx36 knockdown. 
• To use this model to determine the influence of Cx36 on insulin secretion and 
metabolic function. 
 
6.3. MIN6 CELL CONNEXIN 36 KNOCKDOWN MODEL DEVELOPMENT 
 
With the main aim of this chapter being to determine if Cx36 mediates the improved 
functionality of pseudoislets versus monolayers, the first step was to develop MIN6 with 
stable knockdown of Cx36 using shRNA. The pseudoislets form over five days so a stable 
inducible transfection system was chosen over a transient system. This allowed the 
MIN6 cells time to form the pseudoislets before the Cx36 knockdown was induced to 
ensure that experiments focused only on the effects of Cx36 knockdown on function and 
not on the formation of the pseudoislets. A SMARTvector inducible lentiviral shRNA 
system was used. Figure 71 shows the elements that make up the vector and the 
purpose of each one is explained in table 6. This system enabled selection of the 
transduced cells through antibiotic selection, visual identification of transduced cells, 
and an inducible knockdown response in the presence of doxycycline.  
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Figure 71. SMARTvector Inducible Lentiviral shRNA Vector 
 
VECTOR ELEMENT PURPOSE 
5’ LONG TERMINAL REPEAT (5’ LTR) Necessary for lentiviral production and integration into the 
host cell. 
PSI PACKAGING SEQUENCE (Ψ) Allows lentiviral genome packaging. 
REV RESPONSE ELEMENT (RRE) Increases packaging efficiency to enhance titre. 
TERTRACYCLINE RESPONSE 
ELEMENTS (TRE3G) 
Allows induction of promotor in the presence of doxycycline. 




Scaffold based on native primary microRNA in which gene 
targeting sequence is embedded. 
PUROMYCIN RESISTANCE GENE 
(PUROR) 
Allows antibiotic selection of transduced cells 
2A Self-cleaving peptide enabling PuroR and Tet-On 3G 
transactivator expression from a single promotor.  




Enhances transgene expression in target cells. 
3’ SELF-INACTIVATING LONG 
TERMINAL REPEAT (3’ SIN LTR) 
For generation of replication incompetent lentiviral particles. 
Table 6. shRNA Construct Elements 
Elements of SMARTvector inducible lentiviral shRNA vector. Image taken from 
SMARTvector Inducible Lentiviral shRNA technical manual.  
Explanation of utilities of lentiviral shRNA construct elements. Table adapted from 
information in the SMARTvector Inducible Lentiviral shRNA technical manual. 
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6.3.1. Optimisation of Transduction Conditions 
 
Before selecting the construct to be used in this investigation, the optimal conditions for 
transduction of MIN6 cells with the shRNA lentiviral constructs were determined. This 
included cell seeding density, polybrene concentration and FBS presence. Two plates 
were set up following the plate layout shown in figure 72. On the second day the 
confluency of the wells was visually inspected, the seeding density of 30,000 cells/well 
provided the optimal confluency for transduction. Transduction media both with and 
without FBS and at varying concentrations of polybrene was then prepared and added 
to the wells of each plate as shown in figure 43. After six hours, culture medium was 
added to each well of one plate while the other plate was left overnight before culture 
medium was added. The following day, the cell confluency and morphologies were 
examined using a microscope. The MIN6 cells were seen to be detaching and less 
confluent on the plate which had been left overnight but growing well on the six-hour 
transduction plate. The cells also appeared to tolerate the lack of FBS during the six-hour 
transduction and the highest concentration of polybrene tolerated without effecting cell 
growth was 8µg/mL. These were the conditions selected to use in further transductions 




Figure 72. Plate Format for Transduction Optimisation 
 
6.3.2. Selection of optimal Promotor for MIN6 Transduction 
 
To determine the promotor that is most active in MIN6 cells, a SMARTchoice shRNA 
promotor selection plate was used. Using the transduction conditions determined 
previously, MIN6 cells were transduced with seven different SMARTvector non targeting 
controls, each containing a different promotor. The cells were transduced at a range of 
multiplicity of infections (MOIs). The activities of seven different promoters in MIN6 cells 
were imaged and the images displaying the highest expression of GFP for each promotor 
is displayed in figure 73. The mCMV promoter produced the highest fluorescence 
intensity indicating it would be the optimal promoter for use in MIN6.  
 
Template for 96 well plate layout used to select optimal transduction conditions in 
MIN6 cells. The optimal conditions chosen to use in further transductions has been 
marked by a red rectangle.  
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Figure 73. Fluorescence Microscopy Images of SMARTchoice Promotoers 
 
6.3.3. Analysis of Doxycycline induced Connexin 36 knockdown in 
transduced MIN6 
 
Three different shRNAs expressing the mCMV promotor and an inducible shRNA against 
Cx36 were used. These were designated KD1, KD2, and KD3. MIN6 were transduced with 
each shRNA and a scrambled control using conditions described in section 6.3.1. Growth 
media was then supplemented with 1µg/mL of freshly dissolved doxycycline to activate 
the knockdown at various time points over 48 hours. To select the shRNA producing the 
cell line with optimal inducible Cx36 knockdown, western blots were used to measure 
Cx36 expression.  
 
The results from these western blots (figure 74) show that each of the three shRNA 
constructs tested resulted in a lower Cx36 expression than in the MIN6 transduced with 
the scrambled control. There was a gradual reduction in Cx36 expression proportional 
to increased exposure time to the doxycycline with all constructs KD3 showed the 
greatest effect on the Cx36 levels and thus was used for further experiments.  
  
No Promoter hCMV mCMV hEF1α 
mEF1α CAG PGK UBC 
Fluorescence microscopy of MIN6 transduced with SMARTvector 8.0 Non-
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Western blot showing connexin 36 expression in high passage MIN6 pseudoislets 
after five days of culture with doxycycline added for the final 0, 6, 12, 24, 36, and 
48 hours. Samples include MIN6 transduced with three different shRNAs containing 
a Cx36 knockdown gene (KD1, KD2, and KD3) and a scrambled control. Beta actin 
was the housekeeping protein used to normalise. Graph shows mean of normalised 
connexin 36 expression.  N=1 
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6.4. INFLUENCE OF CONNEXIN 36 KNOCKDOWN ON THE INSULIN 
SECRETION RESPONSE OF MIN6 PSEUDOISLETS  
  
The insulin secretion response of the MIN6 pseudoislets with Cx36 knockdown was 
measured in comparison to the response of MIN6 transduced with the scrambled 
control (figure 75). Pseudoislets used in this study were formed in standard MIN6 culture 
media for three days then in media with doxycycline present for a further two days, 
there was no obvious effect of Cx36 KD on pseudoislet formation (results not shown). 
The MIN6 with Cx36 KD showed much higher variability in insulin secretion response at 
both basal and high glucose. The basal insulin secretion was almost 4-fold higher in the 
Cx36 KD compared to scrambled control. The insulin secretion at high glucose also 
appeared higher with the induced knockdown but due to the high basal insulin secretion 
the fold increase in insulin secretion was lower, 2.5 for the Cx36 KD and a 3.7-fold 
increase in the control.   
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Insulin secretion response of high passage MIN6 cultured as pseudoislets for five 
days with connexin 36 knockdown induced on day two. Pseudoislets were 
incubated for 30 minutes in 0.5mM glucose media then one hour at either 5mM 
glucose or 25mM glucose. N=3. Statistical analysis performed but not found to be 





6.5. INFLUENCE OF CONNEXIN 36 KNOCKDOWN ON ATP PRODUCTION 
 
Using the seahorse bioanalyser protocols developed in chapter 4 and the pseudoislet 
protocol as described for GSIS in 6.4, the impact of the Cx36 KD on metabolic function 
was analysed. MIN6 transduced with scrambled control or shRNA encoding inducible 
Cx36 knockdown formed pseudoislets over five days. Doxycycline was present in the 
final two days of pseudoislet culture to induce the knockdown. The pseudoislets were 
then treated for one hour in 0.5mM glucose media before analysing the metabolic 
activity. Figures 76 and 77 show an example experiment displaying the OCR and ECAR 
measurements respectively. There was no consistent effect of Cx36 KD on both basal 
and glucose-stimulated glycolysis as assessed by ECAR. However, there was a clear 
increase in basal rates of OCR following Cx36 KD. The data from three of these 
experiments were then analysed to calculate the ATP production from oxidative 
phosphorylation and glycolysis both with and without Cx36 KD, figures 78-80. 
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Figure 76. OCR of Pseudoislets with Cx36 KD 
 
OCR response in high passage MIN6 Cx36 stable KD model cultured as pseudoislets for 
five days and with doxycycline induction on day two or no induction in the controls. The 
first injection contained either 25mM glucose or 0.5µM glucose injection and 
subsequent injections contained 20µM oligomycin, then 0.5µM Antimycin A. Measured 
on a seahorse XFe24 bioanalyzer. Islets were cultured for 24 hours on a 24 well 
microplate and starved for one hour in 0.5mM glucose prior to the experiment. N=3. 
148 
 
S c r a m b le d  C o n tr o l V s  C x 3 6  K D  E C A R



















C o n tro l B a s a l
C o n tro l G lu c o s e
C x 3 6 K D  B a s a l
C x 3 6 K D  G lu c o s e
B a s a l G lu c o s e O lig o A n tim y c in  A
 
Figure 77. ECAR of Pseudoislets with Cx36 KD 
 
The total ATP production from all metabolic pathways in Cx36 KD and control cell were 
then calculated and are shown in figure 78. This data suggests that the knockdown of 
Cx36 results in a slightly higher basal ATP production and higher ATP production at high 
glucose. However, the fold change in overall ATP Production was 3.03-fold for MIN6 
pseudoislets with the scrambled control and 2.9-fold for the pseudoislets with Cx36 KD. 
These differences between these fold changes is smaller between the differences seen 
between the fold changes in insulin secretion response but do support trends in insulin 
secretion shown in figure 75. The total ATP production is expected to be tightly linked 
to insulin secretion but analysing the separate contributions of glycolysis and oxidative 
phosphorylation to the ATP production can provide more insight into the pathways.  
 
ECAR response in high passage MIN6 Cx36 stable KD model cultured as pseudoislets 
for five days and with doxycycline induction on day 2 or no induction in the 
controls. The first injection contained either 25mM glucose or 0.5µM glucose 
injection and subsequent injections contained 20µM oligomycin, then 0.5µM 
Antimycin A. Measured on a seahorse XFe24 bioanalyzer. Islets were cultured for 
24 hours on a 24 well microplate and starved for one hour in 0.5mM glucose prior 
to the experiment. N=3. 
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The ATP contributions from oxidative phosphorylation are shown in figure 79. These 
results show that the increased basal ATP production in Cx36 KD MIN6 is at least in part 
caused by an increase in basal oxidative phosphorylation. The MIN6 with Cx36 
Knockdown also showed a slight increase in ATP production at high glucose. The fold 
increase between oxidative phosphorylation contributions to ATP production at basal 
and stimulating glucose levels was 1.4 for MIN6 with Cx36 knockdown and 2-fold for the 
control however these increases did not reach statistical significance.  
 
Figure 80 shows the ATP contribution from glycolytic metabolism.  This data shows that 
Cx36 expression does not influence glycolytic activity at basal glucose levels but that ATP 
production through glycolysis is higher at stimulating levels of glucose in MIN6 with the 
Cx36 knockdown.  
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Figure 78. ATP Production in Pseudoislets with Cx36 KD 
Total ATP produced per minute by pseudoislets stimulated by glucose. Measured by 
the seahorse XFe24 bioanalyser. MIN6 pseudoislets formed over five days were then 
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Figure 79. ATP Production from Oxidative Phosphorylation in Pseudoislets with 
Cx36KD 
Total ATP produced per minute through oxidative phosphorylation by pseudoislets 
stimulated by glucose. Measured by the seahorse XFe24 bioanalyser. MIN6 
pseudoislets formed over five days were then cultured for 24 hours on a 24 well 
islet capture plate. N=3. Statistical analysis performed but not found to be 
significant when not indicated.   
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Figure 80. ATP Production from Glycolysis in Pseudoislets with Cx36 KD 
6.6. CONCLUSION 
 
6.6.1. Development of Cx36 Knockdown Model 
 
This chapter aimed to investigate the role of Cx36 in regulating the function of 
pancreatic beta cells. The influence of Cx36 on beta cell function has been investigated 
through a variety of approaches. Firstly, beta cells cultured as dispersed 2D monolayers 
have limited intercellular communication. This dispersal of islets is well known to have 
an immediate negative impact on beta cell secretory function [16, 101].  
Pharmacological agents are able to create chronic or acute inhibition of transport 
through gap junctions without preventing the formation of the islets. However, the 
mechanism of action and specificity of these drugs are not well understood, and 
nonspecific interactions may influence results [95, 162]. Rodent models with partial or 
complete Cx36 KO have reported beta cell dysfunction [89, 94, 140, 163]. Due to the 
time and cost restraints in this study generating a mutant mouse model was not an 
option and as the specificity and half-lives of the pharmacological agents are uncertain, 
Total ATP produced per minute through glycolysis by pseudoislets stimulated by 
glucose. Measured by the seahorse XFe24 bioanalyser. MIN6 pseudoislets formed 




the influence of Cx36 was investigated through a cell line with inducible Cx36 KD in this 
study.  
 
First the inducible Cx36 knockdown cell line was generated in MIN6 cells. The ideal 
transduction conditions, promotor, and shRNA constructs were identified. The 
transduction conditions and promotor conditions found to be optimal in this chapter are 
similar to the ideal MIN6 transduction conditions reported in previous studies [164]. This 
chapter only focused on MIN6 cultured as 3D structures either with Cx36 KD or 
transduced with a scrambled control. The pseudoislets formed over five days with 
doxycycline added over the final two days to induce the knockdown. The addition of 
doxycycline did not inhibit the continued formation of the islets which were inspected 
regularly under a light microscope. Western blots reporting Cx36 expression along with 
fluorescence microscopy to check for GFP expression confirmed successful transduction 
and Cx36 knockdown in the MIN6.  
 
6.6.2. Increased functional activity at Basal Glucose in Cx36 Knockdown 
 
The functional activity of MIN6 pseudoislets with Cx36 knockdown was measured at 
basal glucose conditions. This included measuring insulin secretion through an insulin 
enzyme linked immunosorbent assay (ELISA) and ATP production using a seahorse XFe96 
bioanalyser. The pseudoislets carrying the Cx36 knockdown displayed a higher basal 
insulin secretion and ATP production than the pseudoislets expressing Cx36. This 
increased activity at basal levels was also shown in monolayers in sections 3.7.4, and 4.4 
when compared to 3D structures. It is well known that basal insulin secretion is 
increased when beta cells are dispersed and there is evidence to show that Cx36 is 
required to maintain function at basal levels, so this is consistent with previous studies 
[94, 96, 140, 163, 165]. The Cx36 channels are thought to maintain a low basal insulin 
secretion response by coordinating the basal response between beta cells within the 3D 
structure. Spontaneous bursts of [Ca2+] can sometimes occur in isolated beta cells 
stimulating insulin secretion at basal glucose levels, the Cx36 channels distribute these 
[Ca2+] waves throughout the islet allowing the less active cells to diminish the effects of 
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these bursts from more active cells [95]. It is also for this reason that beta cell function 
measurements are less variable in 3D structures than in 2D structures. The error bars on 
the insulin secretion measurements in figure 75 are much larger for the samples with 
Cx36 knockdown suggesting that the hyperpolarizing waves from individual islets could 
be less well-regulated within these islets.   
 
The data generated using the seahorse bioanalyser suggests that the increased basal 
activity is due to an increase in metabolism through oxidative phosphorylation. The 
levels of glycolytic activity did not alter between pseudoislets with or without Cx36 
knockdown whilst the levels of oxidative phosphorylation increased 1.6-fold with the 
knockdown. This was also the case for monolayers which showed a 1.3-fold increase in 
basal insulin secretion and a 1.7-fold in ATP produced from oxidative phosphorylation 
when compared to pseudoislets. Possible reasons for the increased basal ATP 
production in pseudoislets compared to monolayers was discussed in section 5.9.2 and 
similar mechanisms could be contributing to the increase seen in the pseudoislets with 
Cx36 knockdown.  
 
6.6.3. Reduced Insulin Secretion Response in Cx36 Knockdown 
 
The pseudoislets with Cx36 knockdown demonstrated a lower fold increase in insulin 
secretion and in total ATP production than the scrambled control. However, the ATP 
production from glycolysis was slightly higher in Cx36 deficient pseudoislets. The higher 
rates of glycolytic metabolism may be a sign that the metabolism in the Cx36 deficient 
pseudoislets is not operating at optimal efficiency. Cx36 deficient mice have shown a 
loss of glucose stimulated insulin secretion [140, 163] and so pseudoislets with Cx36 
knockdown would be expected to be glucose insensitive and not produce more ATP or 
secrete more insulin in response to glucose. The responses of the Cx36 KD pseudoislets 
was also much more variable with larger error bars which may be due to reduced 
synchronicity of Ca2+ between beta cells.    
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The increase in glycolysis seen in pseudoislets does not seem to be mediated by 
increased Cx36 channels since this was not reversed by Cx36 knockdown. The GSIS was 
not dramatically inhibited by the Cx36 KD in the pseudoislets and certainly not back to 
the levels seen in monolayer samples suggesting that the effects of pseudoislet 
formation on GSIS was not mediated by Cx36. Overall, it appears that basal insulin 
secretion in the pseudoislets was regulated by Cx36 but GSIS was not.  
 
Insulin release is biphasic starting with an initial burst of insulin from granules that are 
already docked to the beta cell membrane and followed by a pulsatile release but the 
mechanisms behind this are poorly understood [95, 166]. A lack of Cx36 is thought to 
lower the response of the first insulin secretion phase and reduce the frequency but not 
amplitude of the second phase [163]. Further investigation into how the two phases of 
insulin secretion are affected by Cx36 knockdown in vitro could help to improve 
understanding of these mechanisms. It would also be of interest to explore whether the 
improved glucose sensing of pseudoislets displayed through the increased GLUT2 and 







CHAPTER 7. FINAL DISCUSSIONS 
 
7.1. Effects of 3D structure on beta cell function 
 
7.1.1. Improved Function of Beta Cells in 3D Structures 
 
MIN6 beta cells showed improved function when configured as 3D structures known as 
pseudoislets including an enhanced GSIS response (figure 25) mirrored by increased ATP 
production at high glucose (figure 43) and decreased basal insulin secretion. This is 
consistent with previous reports [14, 76-78, 83, 88, 89, 101-103]. Further investigation 
into the changes in metabolic pathways found that the increased basal insulin secretion 
in monolayers was a result of increased oxidative phosphorylation (figure 44) and in 
pseudoislets an increase in glycolysis was largely responsible for the increased insulin 
secretion at high glucose (figure 45). The metabolic enzyme activity of MIN6 maintained 
in 25mM growth media was measured. The activities of most mitochondrial enzymes 
investigated including pyruvate carboxylase, citrate synthase, alpha-ketoglutarate 
dehydrogenase, and malate dehydrogenase, were increased in pseudoislets compared 
to monolayers. The rate of ATP production in response to glucose was the same in 
monolayers and pseudoislets but the glucose responsiveness of pseudoislets was 
greater due to the lower basal OCR. 
 
The activities of glycolytic enzymes were also measured including phosphoglucokinase 
isomerase (PGI), glucokinase, phosphofructokinase 1 (PFK1), aldolase, GAPDH, and 
pyruvate kinase. Most glycolytic enzymes did not show any changes in activity between 
monolayer and pseudoislet samples except PFK1 and GAPDH activities, which were 
higher in pseudoislets. PFK1 activity is an important regulatory enzyme in the glycolytic 
pathway which stimulates the glycolytic pathway [80]. These results show that although 
the 3D configuration improved beta cell function as was expected [14, 76-78, 83, 88, 89, 
101-103], the mechanisms behind the improved function are not simple and more 




Pyruvate carboxylase expression was higher in pseudoislets than in monolayers, this 
enzyme plays an important anaplerotic role in catalysing the conversion of pyruvate to 
replenish intermediates in the TCA cycle. It is known that changes in beta cell PC activity 
correlate with glucose induced insulin secretion as inhibition of pyruvate carboxylase 
inhibits insulin secretion and the islets of diabetic rodents show decreased Pyruvate 
carboxylase expression [156, 159]. It is also thought that pyruvate carboxylase plays a 
role in beta cell proliferation [11]. 
 
7.1.2. Beta Cell Response to Pyruvate 
 
It is important that beta cells do not respond to pyruvate stimulation to maintain good 
blood glucose control as this would result in inappropriate insulin secretion [54, 55]. It 
is not ideal for beta cells to express MCT1 as these would allow transport of pyruvate or 
lactate into the cell and stimulate unwanted insulin secretion causing blood glucose 
levels to drop [147]. MCT1 is a monocarboxylate transporter known to be expressed in 
beta cells of patients with exercise induced hyperinsulinemia. These patients suffer a 
drop in blood glucose levels following exercise as the pyruvate produced enters the beta 
cell [147]. The MIN6 monolayer rate of ATP production through oxidative 
phosphorylation increased in response to pyruvate stimulation, the pyruvate response 
was only seen in monolayers and not pseudoislets or human islets. One explanation for 
this may be an increase in monolayer MCT1 expression. Antibodies were optimised for 
MCT1 detection in control tissue and expression was not detected in the MIN6 beta cells 
from monolayers or pseudoislets. However, this may be because the levels expressed 
were below detection levels but still present. Further investigation through PCR analysis 








7.1.3. Possible Amino Acid Stimulated ATP Production 
 
The transport of endogenous pyruvate into the mitochondria was also investigated using 
the mitochondrial pyruvate carrier (MPC) inhibitor, UK5099 to further understand how 
pyruvate is metabolised once inside the cell. Both monolayers and pseudoislets showed 
a reduction in OCR after addition of UK5099 indicating that the ATP production is reliant 
on pyruvate uptake into the mitochondria.  
 
The fuel source providing the pyruvate being transported into the mitochondria is 
unclear. Although there is some pyruvate present in the media, 1mM, it has been shown 
that the pseudoislets do not respond to extracellular pyruvate, we assume that this is 
because it cannot be transported into the beta cell. Glucose levels in the media are low 
too low to be considered a plausible fuel source, 0.5mM. It is possible that the L-
glutamine in the media is providing a fuel source allowing for the reduction in OCR seen 
after the addition of UK5099. It is also possible that L-glutamine is acting through other 
pathways to influence the beta cell metabolism. L-glutamine is one of the most 
abundant amino acids found in extracellular fluid in vivo and is thought to have both 
acute and chronic effects on insulin secretion [167]. It has been shown to chronically 
alter insulin secretion rates by up regulating 148 genes and downregulating 18 genes 
leading to changes in the beta cells capability to respond to changes in the external 
environment [168]. The acute effects of L-glutamine involve generation of coupling 
factors such as glutathione and glutamate which lead to enhanced insulin secretion by 
indirectly stimulating ATP production [167]. The L-glutamate generated can also act to 
prime insulin secretory granules accelerating the second phase of insulin secretion 
[169]. The investigation of the effects of amino acids on beta cell metabolism goes 
beyond the scope of this study so it was not investigated beyond noting that an effect 






7.1.4. Role of Cx36 in the Metabolic Phenotype of the 3D Structure 
 
A MIN6 cell line with inducible Cx36 knockdown was generated and another transfected 
with a scrambled control. Functional analysis of pseudoislets formed from these cell 
lines found that inhibition of Cx36 expression increased basal insulin secretion. The 
increase in basal insulin secretion appeared to be due to contributions from oxidative 
phosphorylation. Increased basal insulin secretion in the absence of Cx36 is well known 
and is thought to be due to random hyperstimulating Ca2+ waves generated in isolated 
beta cells that would be dampened if the cell were able to transfer ions between cells in 
a 3D structure [94, 98, 140]. Increases in basal insulin secretion in MIN6 monolayers also 
correlated with an increase in oxidative phosphorylation suggesting that Cx36 plays an 
important role in maintaining oxidative phosphorylation rates at basal glucose.  This 
suggests that Cx36 may be playing a more upstream role in regulating energy production 
rather than exclusively regulating calcium. The overall rates of insulin secretion and ATP 
production at high glucose were higher with the Cx36 knockdown but when the basal 
insulin secretion was considered the fold increase was lower. The previous studies using 
Cx36 deficient rodents have shown a decrease in glucose stimulated insulin secretion 
[94]. There was however, an increase in glycolytic ATP production in the Cx36 deficient 
pseudoislets as was seen in the pseudoislets expressing Cx36 and in the human islets.  
 
This data collected using Cx36 deficient pseudoislets demonstrated that a lack of Cx36 
resulted in a similar phenotype at basal glucose to MIN6 cultured as monolayers. Cx36 
seems to be pivotal in regulating basal insulin secretion and this seems to be at least in 
part due to changes in basal ATP production through oxidative phosphorylation. There 
is a trend towards a lower GSIS response, but further studies are required to further 
explore this effect. Cx36 deficient pseudoislets provide a suitable model to further 
investigate the influence of gap junctional proteins on beta cell function involved in the 





7.1.5. Comparison of Function with Human Islets 
 
To demonstrate the relevance of the MIN6 beta cell line model studies to human 
studies, the metabolic function of human islets was also measured using the XFe24 
seahorse bioanalyser. The data collected from the human islets was more variable than 
data from the MIN6 cell line due to the large number of factors human islets are exposed 
to which can influence function. However, even with this variability it was clear that the 
metabolic phenotype of the human islets was similar to the MIN6 pseudoislets. Both 
exhibited low ATP production without glucose stimulation and had no response to 
pyruvate stimulation as would be expected of islets but had been a feature in monolayer 
samples.  
 
There were comparable fold increases in ATP production under high glucose, 3-fold for 
human islets and 4-fold for pseudoislets. There was an increase in oxidative 
phosphorylation, but this was only 2-fold for both MIN6 pseudoislets and human islets 
so was not sufficient in explaining the overall increase in ATP production rate seen in 
either islet type or the subsequent increased insulin secretion response seen in the 
pseudoislets and reported previously in human islets [3, 5, 85]. Both pseudoislets and 
human islets gained most of the stimulated ATP production through glycolysis. This was 
not an expected result as it is largely accepted that tight coupling between oxidative 
phosphorylation and glycolysis is required for optimal insulin secretion [57, 170]. There 
has been very little investigation into the glycolytic contributions to insulin secretion in 
islets so these findings could not be compared to those described in previous literature. 
It is probable that the glycolytic increases were at least in part due to beta cells in the 
centre of the 3D structure being exposed to hypoxic conditions as is explored further in 
the following section, section 7.2.1. but may also indicate that there are other factors 






7.2. In vitro Limitations 
 
7.2.1. Possible Hypoxia in 3D structures 
 
It is known that isolated islets and pseudoislets will normally express levels of hypoxic 
cores to some degree. This is because once removed from the highly vascularised 
pancreas the cells in the centre of the islets are not able to receive enough oxygen as it 
is not able to freely diffuse to the islet core [106, 152]. The levels of hypoxia in the 
pseudoislets used in this study was investigated. An increase in lactate dehydrogenase 
activity would indicate anaerobic metabolism occurring in the beta cells, possibly due 
hypoxia. There was a trend towards increased LDH activity in pseudoislets although this 
did not reach statistical significance. The presence of down-stream targets of hypoxic 
inducible factors (HIFs) was also measured in pseudoislets, these included GLUT1, PDK1, 
and LDH. PCR results indicated a trend towards upregulation of HIFs in pseudoislets 
compared to monolayers but the pseudoislet data was very variable so this could not be 
reliably concluded. It is likely that the variability in the data is due to beta cells towards 
the centre of the pseudoislets being exposed to a much higher risk and potential level 
of hypoxia than those on the outside. The trend towards increased expression of hypoxic 
markers and LDH activity along with the large glycolytic contribution to ATP production 
and lower basal OCR indicate that the pseudoislets and human islets are suffering some 
effects of hypoxia. This supports reports that the presence of hypoxia in in vitro studies 
involving islets and pseudoislets is a factor which must be managed carefully and taken 
into account when analysing results [13, 144, 151, 152, 171, 172].  However, the increase 
in pseudoislet glucose stimulated insulin secretion which is fuelled in part by an increase 
in oxidative phosphorylation compared to monolayers, the lack of increase in basal 
glycolysis and the lower basal insulin secretion compared to monolayers do not support 
a hypoxic phenotype. This implies the changes in the metabolic phenotype are more 






7.2.2. Influence of Passage number on Results 
 
Pseudoislet formation only increased the GSIS response at high passage, above passage 
26. It was only at the higher passage numbers that differences between the pseudoislet 
and monolayers became obvious as the formation of the 3D structures returned the loss 
of the aging cells. To achieve clear data with minimal variability, only the higher passage 
cells were used in this study. Other studies have also chosen to select only older passage 
MIN6 [7, 77, 111, 112]. 
 
7.3. Long Term Significance of findings 
 
This research holds potential for improving treatment of both type 1 and type 2 
diabetes. Pseudoislets showed improved functionality mostly due to increased glycolysis 
which may be a feature of islets in vitro. The high glycolytic contribution to ATP 
production in both pseudoislets and native islets used in research should be noted as a 
possible limitation when using these 3D structures as a research model. Oxygen 
consumption rates of donated islets have already been shown to give an indication of 
transplant outcome [122, 123]. Measuring the individual contributions of glycolytic and 
mitochondrial metabolism could give further information on islet efficiency when 
selecting optimal islets for transplant.  
 
Cx36 has been found to be more abundant in 3D structures than in beta cells cultured 
as monolayers [92, 94, 96, 103, 140, 163]. In this thesis, a potential role for Cx36 
expression in maintaining the ideal metabolic phenotype and insulin secretory function 
at basal levels of glucose has been explored. The preservation of these connections 
through 3D culture describes another area in which improvements in islet culturing 
protocols could reduce loss of function in isolated islets resulting in a higher success rate 





The functional and metabolic features of the MIN6 monolayers and Cx36 knockdown 
pseudoislets were similar to that of beta cells from patients with type 2 diabetes [173]. 
Cx36 has also been shown to have decreased levels in the islets of some T2DM patients 
[174]. Cx36 provides a possible target in the treatment of T2DM, furthering 
understanding behind these mechanisms leading to the loss of function could improve 
preventative and therapeutic drug development.  
 
7.4. Future Directions 
 
 7.4.1. Short term 
 
• To produce a conclusive assessment on the extent of hypoxia in the pseudoislets 
and human islets used through pimonidazole staining, western blot analysis of 
LDH expression, and PCR analysis of MCT4 expression. 
• To investigate whether the increased mitochondrial enzyme activities were due 
to tighter coupling between glycolytic and mitochondrial metabolism or 
increased mitochondrial biogenesis through mitochondrial staining and PCR 
analysis of mitochondrial mRNA.  
• To extend Cx36 knockdown studies through enzyme activity analysis, PCR to 
measure chronic effects on metabolism, and imaging of calcium signalling. 
• To extend human islet studies by dispersing and reaggregating islets and 
assessing the resulting effect on metabolic function. 
 
7.4.2. Long term 
 
Long term goals would be to investigate the effect of transplant-associated stresses on 
cell connectivity. This can be achieved by exposing islets to transplant-associated 
stresses such as hypoxia, glucotoxicity, and pro-inflammatory cytokines and assessing 
changes in Cx36 expression.  The importance of cell contacts in preserving function in 
the transplant setting could be explored by manipulating cell contacts through 
monolayer and pseudoislet culture as well as Cx36 expression to establish whether any 
function lost through transplant associated stresses and Cx36 inhibition can be restored.  
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Pseudoislets could also be maintained in a more normoxic environment through stirred 
suspension cultures to investigate whether this would prevent changes seen in this 
study, this would show if the impact on glycolysis could be prevented and the 
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